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In support ofthe diabetes research of Paul E. Lacy, M.D., Ph.D., and David W. Scharp, 
M.D., the Barnes Hospital Islet Processing Lab was prepared for a March opening. The 
process, developed at the medical school, produces purified, vital islet cells from pancreata 
acquired from organ donors. The lab's technical supervisor, Dan Fraga, is shown at one of five 
isolators in which the organs are washed, dissected, broken down into cell aggregates, purified 
and cryofrozen for banking. The preparations are then pooled for transplantation to diabetic 
patients who have had kidney transplants or are taking immunosuppressive drugs. 
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On The Cover: 
In pursuit of effective gene 
therapy , medical school research­
ers install genes in many types of 
cells. In the experiments recorded 
on the cover, David Leib , Ph.D., 
and Jay Pepose, M.D., Ph.D., 
tested a particular gene promoter 
(the DNA sequence that instlllcts a 
gene to express the protein for 
which it encodes) to demonstrate 
its effecti veness in neurons. They 
were especially interes ted in 
results shown in the third ex­
amples from the left in the bottom 
two rows. The ce lls in those 
samples are retinal cells that 
clearly contain the active gene 
promoter, as shown by the blu e 
stain. Story on page 12. 
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Is a virus the culprit in some cases 
of drastica ll y increased bone density? 
8 
Switching Good For Bad 
Scientists exp lore gene therapies for 
deli vering all they are leaming about genetics. 
12 
Future Vision 
Spiral CT's capabilities put 
a new spin on imaging. 
17 
The Cori Continuum 
Resea rch inspired in one laboratory 
















according to Crane, in­
creased clinician activity 
will benefit research by 
bringing in more pati ents to 
participate in studies. And 
clinical revenues, he adds, 
will help support teaching 
and research activities in 
both the clinical and pre­
clinical departments. 
Professorial titles will be 
the same for faculty on ei­
ther the investigator or clini­
ci an track . 
" In the past, we have lost 
some excellent clinicians and 
teachers because we could 
not promote them," Crane 
says . "I believe the comple­
mentary nature of the clini­
cian and investigator 
pathways should enhance the 
ability of our faculty to excel 
in all aspects of our aca­
demic mission." 
The School of Medicine 
will join good company by 
offering the clinician track . 
Of the nation' s 126 medical 
school s, 1 12 offer tenure 
and , of those, 80 also have a 
clinician track. 
Crane and Drobak both 
applaud Samuel A. Wells, 
Jr., M.D., professor and head 
of surgery, who chaired the 
clinical pathway stee ring 
committee, and William A. 
Peck, M.D ., executive vice 
chancellor for medical 
a ffairs and dean of 
the School of 
Medicine, for their 
initiati ve to secure 
the future for 
clinical 
facuity . • 
SlaltJ>~ Di.·( (~L~ 
BiolllP.li(·al 
(~nlllpniing 
D avid 1. States, M.D., Ph.D., has been named director of 
the Institute for Biomedical 
Computing at the School of 
Medicine . 
David J. States, M.D., Ph.D. 
Formerly a senior staff 
fellow at the National Li­
brary of Medicine's Nationa l 
Center for Biotechnology 
Information (NCBl) , States 
was responsible for the con­
struction and analysis of mo­
lecular sequence databases . 
In conjunction with hi s 
position at the medical 
school , States also directs 
the program in biomedical 
engineering in the School of 
Engineering and Applied 
Science on the Hilltop cam­
pus. States will oversee ex­
pansion of the network 
communication systems that 
will enable more researchers 
to have access to electronic 
data information. "My goal 
T he votes have been cast and certi fi ed by the university' s 
Board of Trustees, and the 
School of Medicine will of­
fer a clinician track for doc ­
tors who spend more time 
teaching and caring for pa­
tients than doing research. 
In a vote open to the en­
tire faculty on November 6, 
amendments to the tenure 
policy to make a cJinician 
track possible were approved 
by a four-to-one margin, ac­
cording to John N . Drobak, 
1.0. , professor of law and 
chairman of the Senate 
Council , an elected body that 
represents faculty interests in 
university policy deci s ions. 
"This is a major change in 
tenure policy resulting from 
a year-and-a-half of dialogue 
between the medical school 
administration and faculty ," 
Drobak says. "There was full 
and open discussion , and the 
end result is that a new 
career path­
wa y for physicians is being 
established that wi II better 
serve the needs of the School 
of Medicine. " 
In awarding tenure , the 
university always has 
stressed the importance of 
research, explains James P. 
Crane, M.D., associate vice 
chancellor and associate 
dean for clinical affairs at 
the School of Medicine. 
While excellence in research 
will remain a critical part of 
the academic mission, he 
points out that the demands 
and complexity of medicine 
make it essential that some 
individuals devote a major 
portion of their time to pa­
tient care and teaching. 
The clinician track, Crane 
says, rewards physicians for 
excellence in patient care 
and teaching. It also should 
assure a stable patient load 
to provide adequate learning 
opportunities for medical 
students and 
house sta ff. In 
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is that network communica­
tions use will become more 
widespread and routine at 
Washington University, an 
institution which already has 
ex pertise in the area of elec­
tronic communications," 
says States. "E lectronic com­
munication s are an impol1ant 
aspect of the research envi­
ronment, and we need to see 
that all of the university has 
access." 
In addition, States will be 
principal investigator on the 
analysis component of the C 
e/egans Genome Sequencing 
Center. His primary research 
interest is large-scal e mo­
lecular sequencing and the 
analysis of genome sequence 
data . • 
Afftliaiioll 
Renp"lvcfl 
Jewish Hospital and Washington Universi ty have renewed their af­
filiation with th e ap proval of 
a new IS-yea r agreement by 
the Jewi sh Hospital Board of 
Directors. The Washington 
University Board of Trustees 
had already approved the 
agreement in principle and 
authorized officers of the 
School of Medicine to com­
plete the negotiations. 
The new contract aligns 
responsibilities according to 
the missions of both institu­
tions and positions them to 
respond to challenges facin g 
medical education, resea rch 
and patient care. 
"This agreement is the 
final step in the creation of a 
sol id foundation on which 
Jewish Hospital, Barnes 
Hospital and the School of 
Medicine will build the 
health care system of the fu­
ture. And Barnes Jewish, 
Inc. (BH) provides the ve­
hicle for Jewish and Barnes 
hospitals to deve lop this sys­
tem in ways that maintain 
the highest quality patien t 
care while reducing costs 
and duplicative services," 
says Wayne M. Lerner, 
D.P.H., Jewish Hospital' s 
president. 
William A Peck, M.D. , 
executive vice chancellor for 
medical affairs and dean of 
the School of Medicine, 
says, "This agreement final­
izes the es tabl ishment of 
partnerships between the 
medical school and its affili­
ated adult teaching hospitals 
- the Jewish Hosp ital ofSt. 
Louis and Barnes Hospital. 
The platform now exists 
from which the Medical 
School and B1I can meet the 
hea lth care challenges of the 
future." 
The agreement between 
the School of Medicine and 
Jewish Hosp ital provides for: 
• the parties to establ ish a 
new Joint Office of Clini­
cal Affairs composed of 
senior mana gement from 
both organizations that wi II 
work with the clinical 
chiefs and hospital execu­
tives to se t and reach joint 
goa ls for clinical care, 
teaching and research; 
• continuing Jewi sh 
Hosp ital ' s independent re­
search programs and its 
residency and nursing 
teaching progra ms; 
• Jewish Hospital to share its 
net revenues with the 
School of Medicine in or­
der to partially compensate 
the school for the costs of 
the medical direction and 
teach ing services provided 
by the faculty, division 
chiefs and department 
heads; 
• strong support of a medical 
staff composed exclusively 
of clinicians who will have 
Sohel HOllored rr)\~if'e 
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 urton Sobel, M.D. , 
professor of medi­cine and director of 
the cardiology division, re­
cently received two career 
honors: He was named presi­
dent-elect of the American 
Professors of Cardiology 
(APC), a national organiza­
tion devoted to exce llence in 
fulfillment of the clinical, 
educational and investigative 
responsibilities of academic 
cardiology programs, and he 
was presented with the 1992 
Herrick Award from the 
American Heart Associa­
tion 's Council on Clinical 
Cardiology . 
Sobel was named presi­
dent-elect of the APC by the 
group's 118 members, all of 
whom are directors of aca­
demic cardiology programs 
around the country. He will 
hold the post for one year 
from January I, 1993 , then 
will serve as president for 
one yea r, succeeding Yale 
University'S Barry Zarut. 
The prestigious Herrick 
Award is given annually to 
recognize a physician whose 
sc ientific achievements have 
contributed to the advance­
ment and practice of clinical 
cardiology. Sobel accepted 
Burton Sobel, M.D. 
the award on November 17 
at the American Heal1 
Association's annual scien­
ti fic meeting . • 
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full- or part-time faculty 
appointments at Washing­
ton University School of 
Medicine . 
The new agreement 
serves as a master document 
governing the broad terms of 
the parties' affiliation. Addi­
tional , subsequent negotia­
tions related to specific 
facets of the new a ffi I iation 





T wo scientists here have been presented with the Wakeman 
Award for Resea rch in the 
Neurosciences, John W, 
Olney, M,D" professor of 
psychiatry and neuropathol-
John W. Olney, M.D. 
ogy, and Dennis W, Choi, 
M,D" Ph,D" Andrew B . and 
Gretchen p, Jones Professor 
of Neurology and head of 
neurology , share thi s year's 
award with Jeffrey C 
Watkins, M,D. , professor of 
pharmacology at the Univer­
sity of Bristol in Bristol, En­
gland. 
The three were recog­
nized for their work in the 
area of excitotoxicity, The 
word, coined by Olney, de­
scribes the process by which 
brain and nerve cells are I it­
erally stimulated to death by 
the brain's neurotransmit­
ters. Excitatory amino acids , 
particularly glutamate and 
aspartate, can have toxic ef­
fects on cells in the brain and 
spinal cord, Injury from 
trauma or stroke and dis­
eases such as Alzheimer's 
cause the release of large 
quantities of excitatory 
amino acids and destroy irre­
placeable brain and nerve 
cells. 
The Wakeman Award is 
considered one of the most 
prestigious in the neuro-
Dennis W. Choi, M.D., Ph.D. 
sciences. "It is a special 
honor, for which I am very 
grateful ," Choi says. " I hope 
to join Drs. Watkins, Olney 
and others in continuing to 
contribute to the excitotox­
icity field," 
For Olney, the award rep­
resents official recognition 
for the first three generations 
of contributors to the field of 
excitotoxicity, Watkins, he 
says, provided the founda­
tion by identifying how 
amino acids alter the activity 
of neurons. Olney later dis­
covered the toxic effects of 
the excitatory amino acids 
and demonstrated their po­
tential role in brain disor­
ders. Choi followed by pro­
ducing glutamate excitotox­
icity in cultured brain 
neurons and clarifying mech­
anisms by which glutamate 
excitotoxicity can contribute 
to neurological disorders. 
"The contributions are not in 
competition with one an­
other, but are rather separa te 
aspects of the same th eme 
that complement one an­
other," Olney says, 
The Wakeman Award is 
presented every two years. 
It was established in 1972 by 
Nancy D.W, Gardiner in the 
memory of her husband, 





R esearchers here have applied the lates t ul­trasound techniques 
to develop a safer method for 
diagnosing kidney s tones 
and other forms of urinary 
tract obstruction, 
Using color Doppler ul­
trasound and conventional 
X-rays, the investigators at 
Mallinckrodt Institute of Ra­
diology produced images of 
blood flow in the kidneys 
and of urine entering the 
bladder to assess whether 
urine made the journey from 
kidneys to bladder success­
fully. The approach may 
help avoid the adverse drug 
reactions that occasionally 
result from the current diag­
nostic test of choice, says 
Lane Deyoe, M.D., a radiol­
ogy fellow. 
Currently , physicians di­
agnose possible urinary tract 
obstructions by using a plain 
abdominal X-ray to look for 
kidney stones and an intrave­
nous urogram (IVU) to as­
sess urine flow. For an IVU , 
patients are injected with a 
contrast material and ab­
dominal X-rays are made, 
The contrast material pro­
duces an image of the path 
urine takes as it leaves each 
kidney and travels through 
ureters to the bladder. Ifan 
obstruction exists, an IVU 
may show the contrast agent 
pooling up behind the block­
age, says Deyoe, 
The IVU is generally 
quite accurate and safe, 
Deyoe says, But in some pa­
tients , the contrast material 
causes adverse reactions 
such as nausea, vomiting, 
irregular heart beat and , in 
extremely rare cases, death , 
Mild to moderate reactions 
affect two to eight percent of 
pati ents; seve re , life-threat­
ening reactions occur in 0,0 I 
percent to 0, I percent of pa­
ti ents , Deyoe says. In addi­
tion , the test is not ideal for 
pregnant women because it 
exposes their fetuses to ra­
diation and to the contrast 
drug, he adds. 
Deyoe and colleagues 
evaluated 32 patients sus­
pected of having a urinary 
tract obstruction using a 
plain abdominal X-ray and 
three ultrasound techniques, 
They used IVU exams as the 
standard for comparison. 
With a traditional ultrasound 
exam of the kidney , they 
looked for urine pooling in 
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the kidney. They also ap­
plied a technique called 
pulsed Doppler to look for 
decreases in blood flow to 
the kidney, which can indi­
cate a urinary tract blockage. 
Third , the researchers used 
color Doppler ultrasound to 
look for "ureteral jets," the 
regular spurts that normally 
send urine into the bladder. 
Color Doppler, based on a 
principle similar to police 
radar, uses sound waves to 
measure the speed of moving 
materials. 
The ultrasound approach 
correctly diagnosed all com­
pletely obstructed patients 
and all patients who were 
completely unobstructed. Of 
14 patients with partial ob­
structions, I I (79 percent) 
were correctly di agnosed. 
There was one false-positiv e 
result in one completely ob­
structed patient Overall , the 
tes ts were accurate in 28 o f 
the 32 patients (88 percent). 
"We found that the ultra­
sound was very good at diag­
nosing these obstructions. 
The IVU is a good test, but 
for patients who sbould not 
receive the contrast material, 
thi s gives us an option," 
Deyoe says. 
Ultrasound , unlike the 
traditional X-ray exams, also 
gi ves physicians the capabil­
ity of looking for othe r 
causes of abdominal pain , 
such as appendicitis or gall­
bladder disease, he adds. The 
ultrasound approach may be 
especially valuabl e for preg­
nant women , the elderly, 
peop Ie who are allergic to 
the contrast material and 
people who have unhealthy 
kidneys, he says . 
Cullen Is Asso('ialt' Viee Cluuu't>llor Fur 
Rt>sf~al"(~h: Lazarus l\anu!(l A.ssislanl [)~an 
Susan E. Cullen, Ph.D., interface with other univer­ position of ass istant dean. has been appointed the sityoffices. She assumed her new role uni versity's associate " Sue Cullen brings her December I. 
vice chancellor for research, faculty and resea rch experi­ "Dr. Lazarus is a fine 
and Cathy J. Lazarus, M.D. , ence, as well as her knowl­ mentor and clinician, in­
bas been named assistant edge of the research office, tensely interested in student 
dean for student affairs at the to thi s important part of the activities," says William A. 
School of Medicine. university's teaching, learn­ Peck, M.D., executive vice 
As the chief admini s tra­ ing and resea rch endeavors. chancellor for med ical af­
tor, Cullen coordinates a ll She has outstanding creden­ fairs and dean of the School 
ac tivities of the research of- tials," says Edward S. of Medicine. " Her many 
talents will enhance our very 
impo11ant and already fine 
student affairs program." 
In her new pos ition, 
Lazarus will assist Patricia 
L. Cole, M.D., associate 
dean for student affairs, who 
will take on the added role of 
director of the Cardiac Cath­
eterization Laboratory at 
Jewish Hospital, part of 
Washington Universi ty 
Medical Center. Lazarus and 
Cole will be respons ible for 
arranging all student affairs 
activities at th e medicalSusan E. Cullen, Ph.D. Cathy J. Lazarus, M.D. 
school such as graduation , 
fice related to external sup­ Macias, univers ity provost. orientation and other events. 
port for research, including Cullen is an immunologi st Lazarus, who is an assis­
funding from federal and who joined the faculty in tant professor of clinical 
s tate agencies, voluntary 1976. In 1985, she was made medicine, will continue as 
health organizations and the 
corporate sector. 
The office helps faculty 
find sources of supp011, pro­
vides ass istance in the pro­
posal submission process, 
handles federal subcontract­
ing, establishes prime con­
tracts with industrial 
sponsors, provides some of 
the university's compliance 
functions and serves as an 
a fu II professor in both the 
Department of Molecular 
Microbiology and the Oe­
pal1ment of Genetics. 
Lazarus, who in 1990 was 
named director of the Wash­
ington University Medical 
Campus Student and Em­
ployee Health Services, will 
continue in that pos ition in 
addition to her responsibi li­
ties with the newly created 
director of student and em­
ployee health service, over­
seeing administration of the 
service and providing direct 
pat ient care to medical cam­ i' 
pus students , including those 
in the medical school , gradu­
ate school of biological sc i­
ences , occupational therapy, 
physical therapy and other 
programs based at the I; 
School of Medicine . • 
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John P. Atkinson, M.D., and Jeffrey 1. Gordon, M.D., have been 
elected to the rank of fellow 
by the American Association 
for the Advancement of Sci-
John P. Atkinson, M.D. 
ence (AAAS). The associa­
tion bestows this honor on 
members "whose efforts on 
behalfofthe advancement of 
science or its applications 
are scientifically or socially 
distinguished." 
Atkinson, professor and 
chairman of the Department 
of Internal Medicine and 
professor of molecular mi­
crobiology, was named for 
his pioneering research in 
immunology, for exemplary 
professional leadership in 
the field of rheumatology 
and for inspiring contribu­
tions as a medical teacher. 
Gordon, professor and 
head of the Department of 
Molecular Biology and Phar­
macology and professor of 
medicine, \vas named for his 
studies on the cellular and 
molecular biology of cells 
that Iine the intestine and for 
analyses of the enzyme N­
myristoyltransferase (NMT). 
Gordon's laboratory has 
used a family of genes en­
coding fatty acid binding 
proteins as models to study 
the atomic details of fatty 
Jeffrey I. Gordon, M.D. 
acid-protein interactions and, 
through the use of transgenic 
mouse technology, to exam­
ine the differentiation and 
proliferation programs of 
intestinal epithelial cells . • 
Pet,li Elevated 
. O.;Xf't·U lyerl' E' " 
Vice Chan('f·lIol· 
W
illiam A. Peck, 
M.D., has been named executive 
vice chancellor for medical 
affairs, according to Chan­
cellor William H. Danforth. 
Peck will continue to carry 
the title of dean of the Wash­
ington University School of 
Medicine as well. 
Peck was named vice 
chancellor for medical af­
fairs and dean of the School 
of Medicine in 1989 and is 
the first person to serve in 
the dual position. As dean, 
Peck administers the aca­
demic, research and patient 
care activities \vithin the 
School of Medicine. As ex­
ecutive vice chancellor, he 
guides and coordinates the 
relationships between the 
school and other organiza­
tions and constituencies, 
such as the affiliated hospi­
tals, the National Institutes 
of Health and corporations 
and foundations. Peck also 
serves as president of the 
Washington University 
Medical Center, which in­
cludes Barnes, Jewish, 
Cbildren's and Barnard hos­
pitals and the Central Insti­
tute for the Deaf. 
"When the decision was 
made to combine the 
deanship and the vice 
chancellor's responsibilities 
into a single position, we 
knew we would need a 
leader with exceptional tal­
ents in the areas of adminis­
tration, education and 
biomedical research," says 
Danforth. "Bill Peck has cer­
tainly proven to have that 
mix of talents and has guided 
the school extremely well 
during a period of growing 
expectations and chal­
lenges." • 
IuYesligalors Lool~ }'Ol" Gcnclie 
Markers In Schizophrenia 
R esearchers at the School of Medicine have received a 
$400,000 grant from the Na­
tionallnstitute of Mental 
Health to study the heritabil­
ity of schizophrenia. 
Steven O. Moldin, Ph.D., 
assistant professor of psy­
chiatry, will evaluate 50 
schizophrenic patients and 
three family members to 
study biological traits com­
mon in patients and their 
relatives who are not suffer­
ing from the disease. All will 
be tested for attention disor­
ders. 
"People with schizophre­
nia tend to have trouble with 
attention. If you ask them to 
follow a moving object or 
perform a task that requires 
attention, they do poorly," 
Moldin says. "Their rela­
tives, who might not have 
schizophrenia, also tend to 
have impaired attention. 
With this study we are trying 
to see how schizophrenia 
and attention together are 
inherited through the fam­
ily." 
Moldin will gather data 
for the five-year grant from 
inpatients at Malcolm Bliss 
Mental Health Center and 
Barnes and Jewish Hospitals 
at the Washington University 
Medical Center, where he is 
an attending staff psycholo­
gist. • 
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arlos A. Perez, M.D., 
director of the Radia­
tion Oncology Center 
a t Washington Univers ity's 
Ma llinckrodt Institute ofRa­
diology , has bee n awarded 
the 1992 Gold Medal Award 
from the American Society 
for Therapeutic Radiologists 
Carlos A. Perez, 11.D. 
and Oncologi sts (ASTRO). 
ASTRO, the largest soci e ty 
of radiation oncologists, has 
given the award since 1977 
to recogni ze outstanding 
contributions to the field of 
radi a tion oncology. Perez is 
among th e youngest ever to 
receive it. 
Louis V. Avioli, M .D., 
and Roberto Civitelli, M.D ., 
have received the Kappa 
Delta A ward from th e 
American Academy of Or­
thopedic Surgeons for their 
outs tanding contributions to 
the fundamental understand­
ing of those factors that con­
trol bone cell activity and 
biologica l function. 
The award is given annu­
ally for outstanding resea rch 
in the field of orthopedics and 
bone metabolism. Avioli is 
Shoen berg Professor of Medi­
cine, and Civitelli is assistant 
professor of medicine . • 
Louis V. Avioli, M.D. 
Shu Iie~ l.Jink 
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AII .. ·rosc'1.-1'( ,~i!-l 
H igh leve ls of insulin an d insulin precur­sors may contribute 
to atheroscleros is in non­
insulin-dependent diabetic s 
by di sruptin g their bodics' 
built-in mechani sm for dis­
so lving blood clots, accord­
ing to inves tigators here. A 
better understanding of these 
clotting disruptions ma y gen­
erate new approaches to 
treating atherosclerosis 
among diabetics . 
The findings prov ide the 
best ev idence to date I inking 
insulin to the high rate of 
card iovascular di sease in 
people with non-insu lin-de­
pendent diabetes (NlDDM) 
- a disease that affects 14 
milli o n Americans, the re­
searchers say. 
Clinical studies have 
hinted that overabundance of 
insulin and its precursors­
the substances from which 
insulin is formed - might 
accelera te atheroscl e ro s is in 
people with NlDDM, hyper­
tens ion or obesity, says 
David Schneider, M.D. He 
and Jane t McGill , M.D., in­
structor of medicine, are lead 
authors of the study. 
In th e first of two studies, 
Schneider and his colleagues 
looked at insu lin 's effect on 
endothelial cells, the cell s 
tha t line blood vesse ls. They 
confirmed reports that insu­
lin stimulates production of a 
substance called plasmino­
gen activator inhibitor type I 
(PAl-I). PA I-I interferes 
with blood chemicals that 
prevent clot formation. 
In th e second study, the 
investigators measured PAL­
I in 69 people : 34 with 
NIDDM, 19 non-diabe tic 
obese and 16 non-diabetic 
lean volunteers. They found 
that obese and diabeti c 
people had abnorma lly hi g h 
leve ls of PAL-I , findings tha t 
confirmed past studies. The 
researchers then went a step 
further to see whether such 
PAI-I level s a ltered the abil­
ity to respond to blood c lots. 
They simulated a blood ves­
se l blockage by apply ing 
pressure to decrease circula­
tion in an arm for 10 min­
utes , then measured levels of 
the natural clot dissolver 
called ti ss ue-type plasmino­
gen activator, or t-PA. Lean 
peopl e responded appropri­
ate ly , by producing the 
hig her leve ls oft-PA re­
quired to brea k up the clot, 
had it bee n rea I. Diabetics, 
however, had no such re­
sponse. The finding marks 
the fir st time resea rchers 
have shown a direct link be­
tween PAI-l levels and an 
impaired response to physi­
ologic stre ss in the same 
group of people. 
The studies sugges t that 
diabetics may not respond 
properly to microscopic 
blood clots th at may form on 
a regular basis, Schneider 
says. "In each of us , a dy­
namic equilibrium exists be­
tween mak ing clots and 
di sso lving them. If there is 
too much PAI-I present, di s­
solution of clots may be im­
paired. The effect of that 
may be persistence or recur­
rence of clotting, which can 
exacerbate atherosclerosis," 
he says . • 
CO""fJoelioll 
n tbe legend accompa­

TI nying th e photograph on 
th e inside front cover of 
th e last issue of Outlook 
(Winter, 1992), Carlton C. 
Hunt, M.D., and Albert Roos, 






Investigators Search For A Virus That Is 

ax Arens, Ph.D., got an unexpected 
phone call last year as he sat in his 
office. "Max," the unfamiliar voice 
said, "this is Michael Whyte at Jewish Hospital. 
Would you like to go fishing?" 
Arens had never met Whyte, but a virologist in 
an academic medical center with approximately 
2,000 researchers becomes accustomed to calls 
from scientists needing help in tracking viruses. 
by Jim Keeley He accepted the invitation. 
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Rare and officially unnamed, a new disorder manifests itself in its victim's bones. Comparative X-rays (a normal left hip on the 
left) demonstrate the disease's dramatic effect on bone density. 
Michael Whyte, M.D., hoped that 
Arens might help solve his puzzle. 
Whyte's problem was that two patients 
with an unusual skeletal disease had 
been referred to him. Whyte proposed 
the fishing expedition to pursue the 
disease's origin. 
In June 1990, Dennis Villareal, M.D., 
a fellow in the division of bone and 
mineral diseases , had learned of a 27­
year-old woman who later appeared in 
Whyte's office complaining of severe 
pain in her legs. Her referring physician 
had taken X-rays that showed dense 
bones. Her medical history was not 
informative; almost everything appeared 
normal , leaving Whyte few clues on 
which to base a diagnosis. 
Eight months later, a second patient 
was referred to Whyte with remarkably 
similar symptoms. The man also had 
dense bones and complained of diffuse 
skeletal pain that had plagued him for 
two years. 
Whyte was perplexed. In the span of 
a year, two patients with dense bones 
had come to his office complaining of 
severe pain. Lab tests seemed nearly 
normal; they did not fit the standard 
profile of any known bone malady , and 
previous doctors had been unable to 
diagnose the exact source of their pain. 
The patients had come to Whyte, a 
professor of medicine, hoping that he 
and other bone experts at the School of 
Medicine could find the cause of their 
mysterious ailments. 
At first, there was no hint that the two 
cases were even related. But after 
persistent work, Whyte uncovered a few 
tan tal izing clues that these two patients 
share a single, rare disease. Past X-ray 
studies showed that years earlier, both 
patients had normal skeletons. Studies 
by musculoskeletal radiologist, William 
A. Murphy, Jr., M.D ., professor of 
radiology, and bone pathologist, Steven 
L. Teitelbaum, M.D., Wilma and 
Roswell Messing Professor of Pathol­
ogy, showed that not only were the 
patients' bones growing denser, but they 
were being built up and broken down at 
twice the normal rate. 
The studies didn ' t explain the cause 
of the abnormal bone growth, but they 
did provide the reason for the patients' 
severe pain. Whyte surmised that as the 
bones thickened and expanded, pain 
fibers anchored at the bone surface 
stretched and fired a pain signal. The 
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Michael Whyte, M.D., and William Murphy, M.D., are among collaborators tracking down the origin and cure for a newly 
identified disorder that accelerates bone growth. 
dramatic bone production probably 
caused the pain fibers to fire often. 
With the pain partially explained, 
Whyte began to consider the nature of 
the prodigious bone formation. The 
patients' histories offered a clue: Both 
patients had been intravenous drug 
abusers who had shared needles with 
others. Whyte saw that their lifestyles 
could have put them at risk of infection 
from viruses that may have been passed 
via contaminated needles. He decided to 
call Max Arens to see if Arens would 
test his patients' blood for suspicious 
viruses. 
Whyte also recalled reports suggest­
ing that viruses may infect bone cells 
and cause dramatic bone thickening in 
other conditions. It occurred to him that 
perhaps the tremendous bone growth in 
his two patients also was caused by a 
virus. 
In fact, the laboratory tests showed 
evidence of Epstein-Barr virus and 
hepatitis C virus in both patients. But the 
fishing trip that Whyte proposed to 
Arens snagged no evidence of Whyte's 
prime suspect, a retrovirus that can 
incorporate its genetic information into a 
host's DNA. As Arens had feared, they 
had reeled in more questions than 
answers. But, like a good fish story, the 
tale was getting more interesting all the 
time. 
Based on negative virology tests, 
Whyte proposed a radical notion: 
Suppose hepatitis C virus or some 
unknown virus accidentally tripped the 
bone growth switch in these patients. 
This rate of new bone growth and 
generalized skeletal thickening appeared 
to be a new syndrome associated with 
intravenous drug use. Uncovering the 
cause of the disorder, Whyte says, could 
conceivably help people with osteo­
porosis who would benefit from reacti­
vating the "on switch" for bone growth. 
Before leaping to the concept of viral 
transmission, Whyte had carefully ruled 
out the possibility that these patients had 
a known bone disease. His review of the 
medical literature turned up several 
diseases that can increase bone mass, but 
none was similar to his patients' 
condition. 
Osteopetrosis - the name means 
"petrified bones" - is a rare disorder 
that often has a genetic origin. Research­
ers understand that this disorder is 
caused by defective bone-removing 
cells. Bone is constructed in layers, each 
layer radiating from the center outward 
like the rings of a tree. Construction is 
well regulated by at least two different 
cell types: osteoblasts and osteoclasts. 
Osteoblasts add layers to bone. They are 
in constant communication with osteo­
clasts, cells that chew away bone and 
recycle some of its building blocks for 
future use. Osteopetrosis is caused by a 
cessation in the orderly breakdown of 
bone. The layers of bone continue to be 
stacked one on top of another with no 
dismantling or recycling. The result is 
bones that increase in size and density. 
Bone biopsies of the two patients 
excluded this disorder. 
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Paget's disease, another ailment that 
spurs dramatic bone thickening, is more 
common than osteopetrosis, afflicting 
nearly 15 percent of the over-65 popula­
tion. It is a "patchy" disorder, Whyte 
says, affecting different bones in 
different people. Some people with the 
disease may have an enlarging hat size, 
because the bones in their skull become 
thicker. Others may notice bowing of 
their legs, since the affected skeleton is 
actually soft. Neither of the patients 
showed classic signs of Paget's disease. 
These patients' bones were gaining 
mass fast. The average human receives a 
new skeleton once every eight years. His 
patients, Whyte says, could probably 
accomplish the same feat in half that 
time. 
Osteopetrosis and Paget's disease 
seemed to be excluded as the cause but 
were not a dead end . The two disorders 
share more than their ability to increase 
the density of the skeleton. Reports in 
medical journals provided evidence that 
Paget's disease and osteopetrosis may be 
caused by viruses. The evidence for 
these disorders is preliminary, Whyte 
cautions, but there is speculation that 
canine distemper virus could cause the 
dense bones of Paget's disease. 
Osteopetrosis can be induced in chick­
ens by certain strains of avian leukosis 
virus. Whyte had these findings in mind 
when he asked Arens to be his fishing 
partner. 
Arens' virology report didn't support 
the notion that a known virus was 
causing the problem, unless hepatitis C 
is the culprit. Hepatitis C is capable of 
causing many symptoms, but no one has 
shown that the virus can switch on bone 
production, says Arens. 
Arens admits that after Whyte'S 
initial phone call he thought he would do 
the virology work and that would be the 
end of it. Now, a little more than a year 
later, he and Whyte are still fishing for 
the cause of this mysterious disease. 
"Dr. Whyte is very persistent," notes 
Arens. 
Their discussion of the disorder is 
qualified by "ifs" and "maybes." The 
two scientists do not say the bone 
growth is the work of a virus - they 
have no proof. But suspicions are that a 
virus of some type is a prime candidate. 
If the cause is viral, Arens suspects it 
will be a long time before that virus is 
isolated and identified. "J think it's 
absolutely reasonable at this point to 
suspect an unknown virus," he explains, 
"but identifying the virus is not without 
its problems." Arens speaks from 
experience. Several years ago, while on 
the faculty at St. Louis University 
School of Medicine, he was asked by a 
local company to help identify a virus 
Medical school virologist Max Arens, 
Ph.D., investigates the possibility ofa 
viral origin for the disease. 
that had run loose in its laboratories, 
contaminating hundreds of liters of cell 
cultures. "We isolated the virus, ex­
tracted the DNA, and discovered it was 
an adenovirus the likes of which no one 
had ever seen before. But finding and 
identifying the virus took a lot of work." 
In August 1991, Whyte took his 
speculations on the road. He presented 
his findings concerning the two patients 
at the 13th Annual Meeting of the 
American Society for Bone and Mineral 
Research in San Diego. "Those who 
came by to see the poster were as­
tounded by the density of the bones," he 
says. Despite the interest of researchers 
at the meeting, it didn't elicit the 
response Whyte had wanted. He'd hoped 
to hear that there were more cases like 
the two in St. Louis. "I would have 
thought that with the frequency of 
intravenous drug abuse, this disorder 
would be more common than just two 
patients who came to St. Louis. But I 
think the publication describing these 
patients will take time to percolate in the 
medical community," he says. 
While writing on the subject, Whyte 
found what he thinks is a third case of 
this syndrome. The published report 
details a young woman with a history of 
intravenous drug abuse who developed 
the same type of painful diffuse bone 
thickening with increased skeletal 
turnover. Whyte writes: " It seems 
unlikely, but remains possible, that the 
intravenous drug abuse of our two 
patients and the similar previously 
reported patient is merely coincidental." 
Whyte and Arens acknowledge that 
pinning down the cause of this enigmatic 
syndrome is going to take time. Whyte 
believes it is a new syndrome and 
speculates that it is associated with 
intravenous drug use. Arens remains less 
convinced, preferring to let the science 
speak for itself. 
Whatever the cause, the two patients 
with this painful bone condition have 
benefited from their visits to the School 
of Medicine. Whyte and his colleagues 
were able to apply lessons learned from 
their research on bone metabolism and 
Paget's disease to stop the accelerated 
bone growth and the attendant pain. "We 
recognized that their dense bones were 
caused by rapid bone formation and 
rapid breakdown, much like Paget's 
disease," Whyte explains. 
The researchers knew from basic 
research done at the School of Medicine 
that Paget's disease is probably caused 
by faulty communication between 
osteoclasts and osteoblasts. Experimen­
tal work showed that quieting the 
osteoclasts, or bone-breaking cells, with 
the hormone calcitonin would also quiet 
the osteoblasts, the bone-forming cells. 
"We were hoping the same thing would I~ I·;I 
happen in our two patients," Whyte says. 
There was danger involved in the 
therapy. Whyte explains: "Say you're 
rapidly breaking bone and rapidly forming 
bone but the net effect is that more bone is 
accumulating. If you shut off the bone 
breakers and the bone formers keep going, 
these people could get worse." Fortunately 
that hasn't happened, and now "both 
patients are feeling much, much better," 
Whyte says . • 
f 
II 
len years ago, medical scientists could identify some of the thousands of disorders that have their origins in imperfect genes, but they had no way of 
knowing where the responsible genes 
were, and they possessed little grasp of 
the protein products that genes are 







by Steve Kohler 
Today, medical science is at ground 
zero in an explosion of knowledge about 
human genes, their products and the 
maddeningly complex ways in which 
they can go wrong. 
The leap into tomorrow requires 
bringing our deepening ken of genetics 
to patients whose genes malfunction. 
Gene therapy, as such science is called, 
proves to be even more daunting than 
unraveling DNA. In addition to locating 
and cloning the genes involved, re­
searchers must gain control over the 
DNA sequences that signal genes to 
express their messages and other 
regulators of gene behavior that may be 
spread out along the chromosome. Then 
they must devise delivery systems to get 
enough "good" genes into place so they 
can do the work that "bad" genes fail to 
do. 
Recombinant theory is already being 
used to create medicines that can restore 
health when faulty genes don't produce 
a necessary protein. And investigations 
are rapidly advancing gene therapy's 
most ambitious vision, in which clini­
cians will replace genes inside specific 
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cells, complete with precise control. 
Three examples of gene therapy research 
being conducted at the School of 
Medicine show the possibilities: 
01-gan •system: Eye 

Application: Retinitis pi gmentosa 

Researchers: David Leib, Ph.D., and 

Jay Pepose, M .D., Ph.D. 

People who inherit the genetically 
transm itted disease retinitis pigmentosa 
(RP) frequently lea rn of their condition 
when they notice their ability to see the 
stars is dwindling. The di sease - a slow 
degeneration of the eye's retinal cells­
begins at the periphery of the retina and 
most often affects the organ' s more 
sensitive light recep tors, the rods, more 
than it does the cones, says ophthal­
mologi st Jay Pepose, M.D., Ph.D. 
Those affected usually lose the ir 
peripheral vision first and lea rn just how 
dependent they are on the edges of their 
sight for navi gating. The di sease 
progresses to take a ll but the 10 per cent 
of vision in the center - true tunnel 
vision - at which point a sufferer is 
lega lly blind. Central vision also may be 
affected in some forms or stages of the 
disease. 
Not an uncommon problem, most is 
known about the autosomal dominant 
form, in which the degeneration ha s 
been identified as being a function of a 
defi c iency in the gene that carries the 
code for a protein named peripherin. 
For researc h purposes, a strain of 
mice called rds (for retinal degeneration , 
s low), has been bred , and both the 
defective rds gene and its correct 
counterpart ha ve been c loned and 
sequenced . Researchers at Southwestern 
University have created transgenic rd s 
mice that possess the correct form of the 
rds gene . "The condition is reversed 
compl ete ly in those mice; the degenera­
tion is resc ued," Pepose says. 
But transgenic humans are not 
poss ible, "so we need a de livery syste m 
for the co rrect ge nes," Pepose explains. 
I n their search for a way to del i ver 
therapeutic genes into the cell s of the 
eye, Pepose and his colleague, Dav id 
One ofthe gelle therapist's helpful tools, beta-galactosidase expressed by all 
inserted gelle, reveals its presence ill telltale blue. Here, the gene was attached to a 
neuron-specific promoter and illstalled in nerve cells using the herpes virus as a 
vehicle. 
Leib, Ph.D ., have hit upon the herpes 
s implex viru s, a vehicle well suited to 
the job. 
" He rpes simplex will infect almost 
any ce ll type," Leib says, "but it only 
persists in a neuron ," or nerve cell. The 
reason is most likely that nerve cells are 
post-mitotic; that is, they are no longer 
di viding. The lack of ne uronal cell 
division allows the virus to persist in 
those cells for the Ii fe of the hos t. 
When herpes virus invades a neuron, 
such as a retinal cell , it circularizes and 
enters a latent state. "B ut that's not a 
passive state," Leib points out. " It sti ll 
generates a lot of RNA. " 
"The herpes simplex v irus makes a 
great Trojan horse," says Leib . "We 
incorporate our therapeutic ge ne into the 
virus' chromosome, then infect the 
neural cell s of the eye." Once the altered 
virus infects a retinal cell , it may remain 
latent over time, expressing the thera­
pe utic protein that its added gene 
encodes. 
The researchers use a crippled herpes 
virus that is made safe by deleting a 
viral gene necessary for replication. The 
vira l particles remain infectious , but 
they cannot make more like themselves, 
because the recipe is missing. Pepose 
and Leib go farth er st ill in manipulating 
the virus to do their work. They add a 
promoter from yet another gene - that 
fo r rhodopsin , the protein that allows 
light to be converted into electrical 
impulses in the eye. Common to retinal 
tissue and powerful, the rhodops in 
promoter charges the therapeutic gene 
with added activity . 
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David Leib, Ph.D., (seated) and Jay Pepose, M.D., Ph.D., work to apply gene 
therapy to the treatment ofretinitis pigmen tosa, in which the eye's light-sensing 
cells degenerate as a result ofa gene flaw. 
And they delete the vims' vhs (for 
virion host shutoff) gene. Normally, that 
gene slows a host cell's production of 
protein so that the vims can subvert the 
cellular machinery for its own use. "It 
shuts off the cell and kills it," Leib 
explains. "By knocking out the vhs gene, 
we reduce damage to the very cells 
we're wanting to fix ." 
How is the cocktail of altered herpes 
virus with its added therapeutic gene 
delivered? Via direct application to the 
target cells. A tiny injector is inserted 
through the clear cornea of experimental 
animals and inserted into the subretinal 
space. The "electric thumb," a device 
engineered for the purpose, gently 
delivers a microliter of virus in solution 
each time a foot pedal is depressed. 
Pepose says the de I i very system can 
treat 90 percent of the retina in an 
application. 
Will the genes delivered via the 
herpes virus produce the missing protein 
and rescue sensory cells in the eye? 
Experiments are in progress to answer 
that question. 
•
Organ system: Liver 
Application: Serum protein deficiencies 
Researcber: Katherine Parker Ponder, M.D. 
Many genetic diseases involve 
proteins made in the liver: Most of the 
coagulation factors in the blood origi­
nate there; the apolipoproteins, deficien­
cies of which can lead to atherosclerosis, 
are expressed there, and the complement 
proteins of the immune system are 
produced in the liver. That wealth makes 
the system of particular interest to 
Katherine Parker Ponder, M.D., who 
concentrates her efforts on developing 
gene therapy there. 
In pm1icular, Ponder in vestigates the 
protein alpha-l antitrypsin, a genetic 
deficiency of which can result in emphy­
sema, and protein C, a blood coagulation 
factor. Working with crippled retrovirus 
to del iver correct genes to liver cells, 
Ponder is showing that it's possible to 
get long-term expression of serum 
proteins, but hurdles remain to be 
overcome. 
The retrovirus has several advantages 
as a delivery system to bring therapeutic 
genes to liver cells, Ponder says. First, it 
is relatively safe. By deleting the genetic 
information the virus needs to package 
copies of itsel f, Ponder takes away its 
ability to remain infectious. She then 
installs the same packaging information 
in a cell line. When the vector DNA is 
transferred into the cells that are making 
empty retroviral particles, its RNA can 
be packaged into a virus capable of a 
single round of infection. In that way, 
researchers make enough viral media for 
their purposes, yet mn no risk of 
multiple rounds of infection. 
Second, a retrovirus has the capacity 
to integrate into the genetic material of 
the cells it infects. That means that it can 
deliver its cargo gene directly to the 
genetic machinery of those cells that 
require it. That DNA will be maintained 
there for the long term. 
The size of the cargo, however, is 
limited ; a certain amount of space is 
required for the information that lets the 
vims infect cells and integrate into 
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A section of liver from a laboratory animal demonstrates the ability ofresearchers 
to deliver genetic payloads. The liver was treated in vivo with a retrovirus carrying 
an inserted gene. The gene expresses a protein that enables a cell hosting the gene 
to be stained; here, blue cells have been genetically modified. 
cellular DNA. But Ponder is working to 
find the smallest amount of viral infor­
mation necessary so that the genetic 
payload she wants to deliver can be as 
large as possible. 
Using the retrovirus delivery system, 
Ponder first explored an ex vivo method 
of gene therapy in which cells were 
removed and treated in tissue culture 
before being reintroduced. Several 
difficulties plague the approach. Cells 
must be manipulated to get them to 
repl icate, necessary before a retrovirus 
can infect them. Ponder says only about 
two percent of the total liver mass can 
be re-injected once it has been treated, 
"or you clog up the works." And the 
technique is time consuming. 
A second approach, done in vivo, 
addresses these limitations. Ponder 
explains that the liver is unusual because 
the structure of the blood vessels there 
a Ilows contact between large particles in 
the blood and liver cells. Thus, virus 
particles can be infused directly. 
Ponder and her colleagues remove a 
large pOl1ion of the liver in lab animals 
to stimulate cell growth and replication 
in what remains. When that replication 
peaks, about 24 hours after surgery , she 
injects the genetically altered retrovirus 
into the portal vein. The researchers then 
have only five minutes in which to work, 
after which time oxygen deprivation 
causes liver cells to die. 
"About one percent of the cells are 
would like to achieve better penetration, 
and work proceeds to produce higher 
levels of infection. But with the in vivo 
method, investigators can treat 12 
animals in two days instead of just the 
one per week they could do using the ex 
vivo approach. 
Ponder explores the possibility of 
getting each infected cell to overexpress 
the desired protein. Expression level is 
largely a function of the gene promoter 
installed with the desired gene. That 
promoter also affects the length of time 
for which the protein will be produced. 
"We now have used a gene promoter 
normally expressed in all cells, installed 
it upstream of our gene for alpha-I 
antitrypsin and achieved long-term 
expression of the therapeutic protein ," 
Ponder adds . 
"We get reliable levels of protein 
production for six months," Ponder says. 
"While we haven't reached therapeutic 
levels for alpha-I antitrypsin deficiency, 
we've been using that serum protein 
primarily because we can check our 
results with a simple assay. The same 
level of expression in other genetic 
disorders, such as hemophilia, would be 
therapeutic. We're now working on 
protein C deficiency, and we ' re getting 
close to the genetic disease ballpark," 
Ponder says. 
Katherine Parker Ponder, M.D., explores the potential ofgene therapy in producinginfected by the virus," Ponder says. She 
therapeutic levels ofserum proteins. 
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Timothy J. Ley, M.D., (seated) directs research into the reactivation ofgenes that 
normally are switched offat birth. Working with him are graduate students Bruce 
Hug and Mike Ulrich (right). 
•
Organ system: Blood 
Application: Hemoglobinopathies 
Researcher: Timothy J. Ley, M.D. 
The expression of genes is not 
constant ; mechanisms exists to switch 
genes on and off. Timothy Ley, M .D., is 
working to understand one such mecha­
nism. His aim is to be able to open a 
particular switch. 
At about the time of birth , humans 
normally change from producing one 
form of hemoglobin , the fetal form, to 
producing another, the adult form, Ley 
explains. At the changeover, the gene for 
fetal hemoglobin is sw itched off and the 
gene for the adult version is switched 
on. All too often, however, the adult 
version of the oxygen-carrying globin 
protein is flawed - either misshapen or 
so reduced in amount as to cause serious 
health problems, depending on the gene 
flaw. 
When the adult hemoglobin is 
malformed, one re sult can be sickle cell 
anemia. A defect that causes too little 
adult globin is called beta thalassemia. 
"An obvious strategy for treating these 
hemoglobinopathies," Ley says, "is to 
reactivate the fetal globin genes." The 
approach is especially attractive because 
a number of adults continue to express 
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fetal hemoglobin, and they suffer no ill 
effects from what is called their Heredi­
tary Persistence of Fetal Hemoglobin 
(HPFH). 
"There is good reason to push 
forward," Ley says. Sickle cell patients 
in some parts of the U.S . experience 
annual health care costs that can average 
as much as $50,000 each. Patients suffer 
intermittent painful c ri ses when mis­
shapen hemoglobin molecules literally 
get stuck in blood vessels and rob tissues 
of oxygen. The I ives of sickle cell 
patients are shortened. 
Tha lassemia is widespread, particu­
larly in Mediterranean and As ian 
countries. Its standard treatment in­
volves regular blood trans fu sions 
beginning shortly after birth . Iron 
removal therapy is the only way to lift 
the burden those transfusions bring, and 
patients can expect to live only into their 
30s or perhaps 40s. Bone marrow 
transplants have been used with success , 
but must be done at an early age, and 
Ley raises the ethical question of 
whether a presc hooler can give truly 
informed consent to a procedure that 
carries a five to 10 percent ri sk of 
causing hi s or her death. 
So gene therapy holds promi se. But 
re-activating one pair of genes among 
the body's 100,000 is easier to explain 
than to do. Ley has been involved in 
work to find a pharmacologic agent that 
will safely re-activate fetal hemoglobin 
genes. Several have been tried, begin­
ning with 5-azacytidine about 10 years 
ago and continuing to recent, widely 
reported work with butyrate compounds. 
Some of these drugs insult the bone 
marrow so that it begins to make more 
fetal hemoglobin when it recovers. 
Others, origina lly cancer drugs, block 
the methylation of DNA on the theory 
that unmethylated fetal globin genes are 
more active. 
"But none of these agents wil I be the 
cure," Ley says candidly. "You can ' t get 
comfortable using them in children 
when you don't know the effects 30 or 
40 years down the road. What assurance 
do we have that we're not also activating 
an oncogene that causes cancer? If you 
blindly manipulate blood cell ' programs ' 
and you're wrong, you ' re go ing to get 
another problem , perhaps worse than the 
one you started with," he says . 
A complicated alternative , Ley says, 
is first to remove some of the patient's 
bone marrow and purify the stem cells 
(from which aU blood cells are derived). 
Stem cells account for perhaps one in 
every 10,000 cells in the bone marrow. 
Into those cells, researchers would then 
somehow deliver normally regulated 
globin genes before destroying the 
diseased marrow and installing the 
corrected version. 
Several major problems must be 
confronted before that approach can 
work. Ley says that it is not yet possible 
to fully identify stem cells, and the 
genetic therapy would have to treat 
every one to be effective. " Perhaps most 
difficult," he says, " is that the gene you 
transfer has to be perfectly regulated. If 
it doesn't make enough globin, you 
haven't solved the problem. If it makes 
too much, you've created what's called 
alpha thalassemia , another destructive 
disease. So the regulation has to be 
precise. And that' s a tall order right 
now." 
"Still," Ley says, " that would be the 
very best method." And so researchers 
continue to pursue means to overcome 
the hurdles that stand in the way of 
replacing bad genes with good ones . • 
Spiral CT Improves Upon The Standard 
by Juli Leistner 
omputed tomography, or CT, has 
earned its place as a clinically[ 
valuable exam, but sometimes 
the bread-slice images it provides are 
not enough. Small abnorma lities may lie 
between slices and remain undetected. 
Others may be obscured by the plane of 
view. And if the original slices do not 
meet diagnos tic needs, the only option is 
to scan the patient again. 
Now a new twist on conventional CT, 
called spiral CT, is giving radiologists 
and their colleagues a clearer window 
into the human body. Hailed as a major 
advance in imaging, spiral CT reduces 
the hit-or-miss problems of conventional 
CT, helps radiologists generate more 
diagnostically powerful images, and 
opens up new app lications as well. 
For a conventional CT exam, a donut­
shaped structure called the gantry rotates 
an X-ray beam once around the patient 
for each slice. For the next slice, the 
gantry must be rotated back to its 
original position and the table moved 
forward in a carefully controlled 
increment. A computer assembles a 
cross-sectional image after each scan. 
Conventional CT has several draw­
backs, explains Jay He iken, M.D ., 
associate professo r of radiology and co­
director of the body CT sec tion at 
Washington University ' S Mallinckrodt 
Institute of Radiology. One of the 
biggest problems comes from respiratory 
motion. Patients must hold their breath 
during each scan to minimize motion; if 
breathing is inconsistent from one slice 
to the next, a small lung or liver lesion , 
for example, might be missed, he says. 
And, because the exams take several 
minutes to complete, it is sometimes 
impossibl e to collect all of the data 
during the limited time when contrast 
materia1 provides the best enhancement. 
Also, the computer only holds data for 
each slice; "If there is something in 
between that needs to be imaged, we 
have to rescan the patient," Heiken says. 
17 
Stuart Sagel, M.D., and Jay Heiken, 
M.D. 
Spiral CT eliminates many of these 
problems, Heiken says. Mallinckrodt is 
one of the first sites in the country to 
evaluate it. Investigators Michael 
Vannier, M.D. , professor of radiology 
and chief of the clinical research 
division ; Stuart Sagel , M.D., professor 
of radiology, chief of the chest radiology 
section and co-director of the body CT 
section; James Brink, M.D., assistant 
professor of radiology , and others have 
studied the technology for the past 18 
months. 
The secret to its power is continuous 
scanning. An innovation called slip ring 
technology allows the X-ray tube and 
detectors within the gantry to spin 
around the patient continuously as the 
table glides forward. Because the table 
travels during the scanning process, the 
recorded X-rays plot a spiral course 
through the body instead of a circle . A 
computer stores raw X-ray data as one 
volume, a three-dimensional memory of 
the entire scanned area. The machine 
speeds through a complete exam - of 
the chest, for example - in about 30 
seconds. 
Because spiral CT is so fast, scans are 
accomplished in a single breath-hold , 
eliminating respiratory motion problems. 
The speed also means radiologists get 
better diagnostic information, because 
they can do the entire scan when 
contrast enhancement is at its peak, 
Heiken says. In addition, they can often 
reduce the dose of expensive contrast 
material by approximately 50 percent in 
chest scans and 25 percent in abdominal 
scans without reducing image quality. 
After a scan, the computer can 
construct a set of slice images at any 
interval the radiologist chooses, typi­
cally from 2 to 10 mm. [fnecessary, the 
radiologist can go back to the com­
puter ' s data set and generate thinner 
slices even after the patient has gone 
home. It also is possible to compose 
three-dimensional images and images in 
any plane; when a transaxial cross 
section is di fficult to interpret, an image 
reconstructed in a longitudinal plane 
often provides more information, Heiken 
says. Multiplanar and 3-D images were 
possible with conventional CT, but 
inconsistencies from slice to slice 
limited their quality, he adds. 
Although spiral CT is still considered 
investigational, clinical studies are 
uncovering its practical benefits. Studies 
show spiral CT finds more small lesions 
in the liver than conventional tech­
niques, Heiken says . At Mallinckrodt, 
spiral CT is used routinely for exams of 
the pancreas and for many exams of the 
neck, chest and abdomen. "We are 
generating diagnostic images with spiral 
CT that were not possible before. 
On the left, a conventional, invasive 
arteriogram. On the right. a 3-dimensional, 
color-enhanced reconstruction produced via 
spiral CT. The spine is in green; the left 
carotid artery is in yellow, showing the 
blockage ofthe internal carotid that should 
supply oxygen to the brain. The right 
carotid artery, in red and not blocked, shows 
to both branches. 
These bone scans were produced using 
spiral CTfrom data collected in jive 
minutes instead ofthe usual 20 min­
utes, with radiation dosage reduced by 
60 percent. 
Because we can reconstruct images at 
arbitrary intervals and we avoid respira­
tory misregistration, we can pick up 
lesions that we might otherwise miss," 
he explains. 
Spiral CT also measures lesion 
density more accurately - important for 
deciding whether lesions are malignant, 
Heiken explains. Spiral CT's flexibility 
assures that radiologists can get slices 
through a lesion's center for the most 
accurate density reading, he says. 
Spiral CT also may provide a safer 
alternative to certain invasive imaging 
exams. A recent clinical study by Brink 
found that spiral CT rivals the gold­
standard, cholangiography, for diagnos­
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ing bile duct obstruction. Similar 
benefits are possible for imaging blood 
vessels that suppl y the kidneys, Heiken 
says. Preliminary work shows spiral CT 
may be va luable for imag ing blockage 
and narrowing in the carotid arteries, the 
vessels that lead from the aorta to the 
head, says Christopher Moran , M.D., 
assistant professor of radiology. He uses 
scan data to generate 3-D color images. 
"The information they provide is similar 
to angiograms," he says. Spiral CT also 
shows promise for imaging aneurysms in 
the head , he adds. 
Kevin McEnery, M.D., instructor of 
radiology , is app lying spiral CT to bone 
fractures. He and Anthony Wilson, 
M.B., Ch.B., associate professor of 
radiology, and William Murphy, M.D., 
professor of radiology, are among the 
few researchers anywhere studying this 
app lication. "Conventional CT is used 
when complex fractures are difficult to 
accurately assess on plain X-ray or when 
clinicians need more detailed infonna­
tion regarding the fracture," McEnery 
says. " For musculoskeletal CT imaging, 
when we want to create high quality, 3­
D images or multiplanar reconstructions, 
ma ny thin sections are necessary." With 
standard CT, the exam could take 20 
minutes or longer. "A patient who is in 
pain usually can't be expected to hold 
still that long," he says. Even subtle 
movements cause misalignment of the 
slices and degrade the images. 
"We are excited about spiral CT. We 
can shorten examination times, reduce 
the radiation dose to the patient and 
obtain better data because there is much 
less chance of a patient moving during 
an examination that lasts only 30 
seconds," he says. 
Another likely application will be 
helping surgeons zero in on targets with 
3-D and multiplanar images. It also may 
benefit children, trauma patients and 
others who have difficulty following 
breathing instructions , Heiken says. And 
short scan times are a plus for unstable 
patients, McEnery adds . "As soon as the 
scan is done, the patient can go right 
back to intensive care, even though we 
still are working on the exam at the 
computer," he says. 
Washington University is one of five 




James A. Brink, M.D. 
Siemens Medical Systems, about future 
refinements. Studies by Brink and others 
are helping define the technical param­
eters that generate the best results. And 
Vannier is developing better computer 
algorithms to turn raw scan da ta into 
meaningful pictures . 
According to Vannier, in the future it 
is likely that spiral CT will replace the 
conventional method , and Mallinckrodt 
is embarked on a long-term, cooperative 
development plan to refine and improve 
CT imaging. "Eventually, this will be 
the way routine chest and abdominal CT 
is done. I would estimate that within five 
to 10 years, all major medical institu­
tions will be using spiral CT routinely 
for body imaging," Heiken predicts . • 
Black arrows mark a leiomyosarcoma arisillg from the wall ofthe inferior vella 
cava (yellow arrows). The large organ is the liver. III the left image, reformed from 
a stack ofcOIII'entional CT slices, the information is less thall clear because at least 
100 seconds and several breaths were required to collect the data. In the spiral CT 
image 011 the right, spiral slices were gathered ill a single breath-hold, reducing 
misregistratioll. 
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I n October of 1992, Edwin Krebs, M.D. '43, shared the Nobel Prize in Physiology or Medicine for research on reversible protein phosphoryla­
tion, a crucial process that regulates many enzymes and greatly affects cell 
growth and differentiation. This most recent laureate began his distinguished 
career 47 years ago in the laboratory ofCarl and Gerty Cori, who themselves 
shared the 194 7 Nobel Prize. The connecting link is a rare intellectual 
phenomenon: a generation of Cori-inspired research excellence that has 
flourished for nearly 50 years. 
Krebs belonged to a group of brilliant 
young scientists who launched their 
careers under the Coris' auspices. 
Among them, Krebs and the late Earl 
Sutherland, M.D. '42, started research as 
medical students. While Sutherland 
assisted the Coris, Krebs worked in 
Philip Shaffer's laboratOlY and later held 
a postdoctoral fellowship with tbe Coris 
from 1946 to 1948. Like Sutherland, 
who won the 1971 Nobel Prize for 
discovering cyclic AMP, Krebs followed 
a line of inquiry clearly opened by the 
Coris' research. 
Another alumnus of what might be 
called "the Cori School," Arthur 
Kornberg, a 1969 Nobel laureate for 
research on DNA replication, described 
their laboratory as, "a haven for ambi­
tious, gi fted people from all over. .. right 
after the war it was the liveliest enzy­
mology lab in the world ." Yet, he notes 
regretfully, "My students are now totally 
unaware of the work and spirit of Carl 
and Gerty Cori and of their guiding 
influence on my generation of biochem­
ists. " 
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Carl and Gerty Cori are pictured in their laboratory on October 4, 1947, at the time that they won tire Nobel Prize. Their 
tremendous illfluence cOlltinues to reverberate through tire scielltific community. 
Krebs' 1992 prize is the most recent 
sign of the Coris' guiding influence. 
They generated future research excel­
lence by nurturing young scientists in an 
extraordinary laboratory environment. 
Though Gerty Cori died in 1957 and 
Carl Cori in 1984, their scienti fie legacy 
remains vibrant. They are among those 
few scientists to achieve two kinds of 
intellectual immortality - not only 
through their own discoveries but 
through those of their students. By both 
measures, the Coris' record is remark­
able. 
Their collaboration began when they 
were medical students in Vienna, where 
they received medical degrees in 1920. 
In what Carl Cori later called "the 
doctors' dilemma," they realized that 
post-war prospects for finding two good 
positions in the same place were poor. 
The years 1920-21 were a time of near 
starvation in Vienna; while working as a 
pediatric intern, Gerty Cori developed I 
symptoms of vitamin A deficiency. .~ 
Although Carl Cori managed to get a job 















Edwin Krebs received the Nobel 
Prize last year. He was a research 
fellow in the Department of 
Biochemistry from 1946 to 1948 
after receiving his medical degree 
from the school in 1943. 
sphere there as "very disturbing." To 
be hired, he had to prove Aryan descent. 
Even experimental animals were hard to 
obtain. He recalled: "I was the only 
person.. .in a position to do experimental 
work ... because my father...had been able 
to send me a shipment of frogs. These 
were kept in an aquarium under lock and 
key and were responsible for my coming 
to the United States." In 1922, an 
American laboratory director became 
interested in his studies and offered him 
a position at the New York State 
Institute for the Study of Malignant 
Disease. Gerty Cori arrived six months 
later and went to work in the pathology 
department. 
Carl and Gerty Cori's coUaboration 
on carbohydrate metabolism began 
shortly after their arrival, but they soon 
encountered institutional obstacles to 
working together. In a memoir, Carl 
Cori recalled that, at one point, his wife 
faced being fired "unless she stayed in 
her room and stopped working with me." 
When he decided to consider a job 
elsewhere, Gerty Cori was taken aside 
and told "she was standing in the way of 
my career, and that it was un-American 
for a man to work with his wife." 
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Nonetheless, they persisted in working 
together. 
In 1931, their most fruitful years 
began in the Department of Pharmacol­
ogy at the School of Medicine. Despite 
nepotism rules then in force, Dean Philip 
Shaffer was wise enough to welcome 
them as a team. As head of pharmacol­
ogy, Carl Cori carried major administra­
tive and teaching responsibilities. 
Nonetheless, he continued research with 
Gerty Cori (who received an appoint­
ment as research fellow). He was well 
aware that, as he later put it, "a most 
exciting period in biochemistry had 
begun to unfold ... all previous expecta­
tions about the rate of development of 
biochemistry were surpassed." 
The Coris played a leading role in 
that accelerated development. Between 
1930 and 1935, they published a series 
of papers analyzing what became known 
as "the Cori cycle" - elucidating the 
mechanism of blood glucose regulation. 
While their work opened up several 
other areas of research, a decision to 
focus on glycogenolysis proved wise, for 
it was the most fruitful field of study. 
Arthur Kornberg has provided a 
penetrating description of their ap­
proach: "Carl and Gerty had the experi­
mental gifts and wisdom to extend 
physiological studies of whole animals 
and organs to crude cell ex tracts and, 
finally, to purified enzymes ... while 
teaching themselves and their students 
how to examine the molecular shapes 
and operations of enzymes, they never 
relinquished their devotion to under­
standing the function and hormonal 
control of enzymes in the intact animal." 
In 1947, the Coris shared the Nobel 
Prize with Bernardo Houssay for 
research on the catalytic conversion of 
glycogen. At the Nobel dinner, Carl Cori 
referred to collaborating with his wife: 
"Our efforts have been largely comple­
mentary, and one without the other 
would not have gone so far as in 
Luis F. LeLoir, Nobelist in 
Chemistry in 1970, received the 
prize for his discovery ofsugar 
nucleotides and their role in the 
biosynthesis ofcarbohydrates. He 
was a research assistant to the 
Coris in 1943. 
Arthur Kornberg (left) and Severo Ochoa, Nobel Prize winners in 1959, 
discovered the mechanisms in the biosynthesis of ribonucleic acid and 
deoxyribonucleic acid. Ochoa worked in the Coris' lab in 1941 and 1942; 
Kornberg was a visiting investigator there in 1947. 
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collaboration." In describing their 
laboratory work, a biographer noted, 
"The manual labor and tedium of these 
experiments were considerable. Collabo­
raWrs were few in number by prese-nt­
day standards, and automation was 
nonexistent." 
Despite these difficulties, the Coris 
always attracted young scientists to their 
laboratory. In his 1971 Nobel lecture, 
Earl Sutherland recalled: "When I 
returned to St. Louis after medical 
service in World War II, I was unde­
cided as to whether I should enter 
medical practice or go into research. 
Cori convinced me, not so much by 
anything he said so much as by his 
example, that research was the right 
direction to take." In fact, Sutherland 
had co-authored a 1941 article (his first) 
with Carl Cori while still a medical 
student. His retrospective view is telling, 
for it reveals how the Cori-created 
laboratory environment shaped his 
future: "I believe that kind of stimulat­
ing environment, with the necessary 
critical mass of young and talented 
investigators, with the opportunity for 
Christian de Duve won the 
Nobel Prize ill 1974 for discov­
eries concerning the structure 
and functional organization of 
the cell. He worked in the Cori 
lab as a Rockefeller Foundation 
Fellow and collaborated there 
with Earl Sutherland. 
was no research factory with people 
following detailed protocol laid out by 
others; it was a collection of extremely 
talented individuals doing their own 
work with their own hands. In that 
environment, sinking was unthinkable. I 
felt privileged to be present ...." 
What was the magic of the Coris' 
lab? Sutherland identified two crucial 
ingredients: a critical mass of talented 
young scientists and the free exchange 
of ideas. By today's standards, their 
laboratory was small and modest, but the 
level of intellectual activity and scien­
tific discourse was extraordinary. Severo 
"{9-wc#whaO~beell/!wyef!/ 
comjJ!enzuuaJ':!/J andO/ll?/ {oitltotd t/zl?/ 
~~ {OOldd/ltK~8h/le-80-fo~~ a& 
• - - //- /: - -._",-//l,..n. -'-' Ul/ COllllOOf-u.uAJTy. 
the free exchange of ideas, is an impor­
tant ingredient in the making of scien­
tific progress." This acknowledgment 
meant enough for Cori to quote it in a 
posthumous National Academy biogra­
phy of his fOimer student. 
Washington University Chancellor 
William H. Danforth, M.D., also was 
among those who worked in the Cori lab 
and had the course of his life affected by 
the association. At Carl Cori's memorial 
service, on November 16, 1984, 
Danforth said, "The Cori department 
Ochoa, a 1959 Nobel laureate who 
worked there in the early 1940s, noted 
that "everyone was invited to comment 
on papers before publication." 
As Krebs recently recalled: "The 
training I received in the Coris' labora­
tory as a postdoctoral fellow provided 
me with the actual tools that I needed to 
get started.... By 'tools' I'm referring 
not just to techniques but also to a host 
of other things that go into research ~ 
inquisitiveness, thoroughness, breadth of 
interests and hard work. Gerty Cori's 
Earl Sutherland received the 
Nobel Prize in 1971 for his 
discovery concerning the meclla­
nisms ofhormones. He was a 
student laboratory assistant from 
1940 to 1942 and later an instruc­
tor, an assistant professor and an 
associate professor. 
highest praise for someone was to refer 
to him or her as a 'good worker.' ...The 
actual scientific contributions of the 
Coris served as the basis for what was to 
become my major life's work .... My own 
research was built on the foundation that 
they laid." 
After the Coris' 1947 move to the 
Department of Biochemistry, their 
research group grew considerably. Even 
so, the atmosphere of mutual collabora­
tion and collegial support remained. 
Enriched by the experience, former 
laboratory members would make 
independent contributions to knowledge 
in uoiversities across the country and 
around the world. 
Lo 1953, Gerty Cori wrote: "For a 
research worker, the unforgotten 
moments of h.is l.ife are those rare ones 
which come after years of plodding 
work, when the veiJ over nature's secret 
seems suddenly to lift and what was 
dark and chaotic appears in a clear and 
beautifui light and pattern...." Thanks to 
formative years in the Coris' research 
enterprise, many other scientists have 
experienced those moments. • 
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Personal Outlook 
The tritieal Link: Health altd Human Rigltts 
by Jonathan Mann, M.D. 
T he worldwide AIDS Rights. Briefly yet power­ vel oped and as tools such as The inferior role and low epidemic was the first fully, the universal declara­ the HIV serologic test be­ status accorded to women epidemic to arise dur­ tion responded to the came available, direct con­ results in their inability to 
ing the modem era of human atrocities of Nazi Germany flicts arose between public say "no" to unwanted or un­
rights. As a result, it is not with a clear statement that health experts and human protected sexual intercourse. 
surprising that the dialogue all people are born with rights advocates . Health offi­ Thus, despite their knowl­
between public health and rights that adhere to them cials often acted as if health edge about HIV / AIDS and 
human rights perspectives simply because they are hu­ objectives (preventing HIV even despite the availability 
man and that governments spread) and human rights of condoms, these women 
cannot take away. Since the objectives (protecting the face a choice between refus­
adoption of the declaration rights and dignity of the in­ ing sex, with the likelihood 
in 1948, an important foun­ dividual) were at logger­ of physical violence and di­
dation of documents and in­ heads. vorce (leading basically to 
stitutions and a network of For example, some public civil and economic death), 
nongovernmental organiza­ health officials promoted and risking HIV infection. 
tions have been created to mandatory screening for In response to this situa­
explore the meaning and to HIV infection, while rights tion , women's organizations 
work to ensure respect for advocates resisted practices are working to reform the 
the entire range of human which threatened individual laws and customs governing 
rights. freedoms. In the end, the hu­ property distribution after 
I think my own experi­ man rights viewpoint gener­ divorce. If civil and eco­
ence is somewhat typical. I ally prevailed, as health nomic survival following Jonathan Mann, M.D., 
never encountered the idea officials came to the prag­ divorce can be assured, HIV M.P.H. 
of human rights in any for­ matic conclusion that if the prevention will be helped 
during the HIV pandemic mal sense during either my people they wanted to reach much more than it would be 
has been complex and some­ medical or public health with education about HIV by the distribution of addi­
times difficult. Yet, through training. Indeed, most physi­ were punished or threatened, tional condoms or brochures 
this experience, a clearer un­ cians are unfamiliar with the they would go underground on AIDS. The general mes­
derstanding of the inextri­ basic concepts, the docu­ and not participate in pre­ sage from this specific ex­
cable linkage between health ments, the institutions and vention programs. ample is clear: The fact of 
and human rights has led to the practices of modern hu­ However, as the pan­ being marginalized, stigma­
the creation of a new field of man rights . Yet, as I hope to demic intensi fied and spread tized or discriminated 
academic research, teaching demonstrate, there are practi­ to countries worldwide, an­ against in society is at the 
and practice - and to the cal and powerful reasons - other dimension in the rela­ basis of an increased risk of 
world's first center focusing beyond simply being an edu­ tionship between health and being exposed to HIV. 
on this critical relationship at cated person - for physi­ human rights emerged. Let Once it is clear that dis­
the Harvard School of Public cians and other health me explain using an ex­ crimination increases \rulner­
Health. workers to become literate in ample: In parts of Eastern ability to HIV - through 
The modern era of human human rights. Africa today, monogamous, having less access to infor­
rights started after World Back for a moment to the married women are becom­ mation, services and support, 
War II, with the approval by AIDS pandemic. During the ing infected with HIV. Their or by being less able to put 
the United Nations General early years , as policies and risk factor is their powerless­ into practice the practical 
Assembly of the Universal guidelines for preventing ness to influence their implications of prevention 
Declaration of Human HIV transmission were de- husband's sexual behavior. messages - the way for­
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ward for public health 
against ArDS is clear. Not 
only must existing programs 
of education, health and 
social services and social 
support continue to be devel­
oped and strengthened, but 
we must remove and prevent 
societal discrimination. 
Thus, for example, promot­
ing an equal role for women 
becomes a critical strategy 
for improving public health. 
Looking beyond AIDS, 
we can see at least three di­
mensions in a health and hu­
man rights relationship. 
First, it is clear that abuses 
of human rights - - whether 
torture, or inhumane treat­
ment during imprisonment, 
or rape or denial of the right 
to information have im­
portant health impacts. Yet 
even these impacts are often 
not well documented, or un­
derstood. 
For example, we now 
know that prolonged impris­
onment under inhumane con­
ditions creates lifelong 
threats to physical and men­
tal health which require pre­
venti ve services and care. 
Still another example in­
volves rape during warfare 
or undeclared conflict. The 
tragedy in Bosnia is particu­
larly abhorrent because rape 
has apparently been a sys­
tematic and deliberate 
policy. But how much is 
known about the frequency 
and incidence and conse­
quences of rape during other 
conflict situations, including 
insurgencies and various un­
declared conflicts? It is im­
portant to document the 
health consequences of hu­
man rights abuses, system­
atically and carefully, in 
order to understand better 
how to prevent their occur­
rence and to ameliorate their 
impact. 
A second dimension of 
the health-human rights rela­
tionship involves the ways in 
which health policies, pro­
grams and practices can have 
adverse effects on human 
rights. For example, the 
practices of quarantine and 
isolation are part of the lexi­
con of public health re­
sponses to epidemic disease. 
But these practices violate 
individual rights. How effec­
tive is isolation, and what are 
its direct and hidden costs? 
Is the evidence strong 
enough to justi fy burdening 
human rights? Before jump-
of human rights as legitimate 
concerns require that health 
workers become human­
rights I iterate. 
The third dimension re­
turns to the recognition that 
social justice - or to put the 
matter negatively, societal 
discrimination - is critical 
to efforts to promote hea lth. 
While the general relation­
ship between health and 
rights - such as the right to 
information, to education, to 
recognition as a person be­
fore the law, to freedom of 
movement, to the right to 
marry and found a fami Iy, to 
In the n1HtIerll wnrl(l.
/ 
tlu~ existence 
and acknowledgnlcnt of (uIluan 
rights as legititnate concerns 
require that health workers 
he(,(Hnp hLllnan-rights li tera te. 
ing to conclusions, we must 
reca 1I tha t medica I leaders 
actively participated in de­
veloping Nazi ideology and 
practices, under the guise of 
the pseudo-science of racial 
hygiene. By taking the con­
cept that the "diseased" part 
must be sacri ficed for the 
health of the rest, Nazi doc­
tors promoted the practices 
(starting with euthanasia and 
killing of the handicapped) 
which led directly to the 
death camps. What was 
missing so desperately from 
Nazi Germany was respect 
for individual human rights. 
In the modern world, the ex­
istence and acknowledgment 
freedom of opinion and ex­
pression - is clear, the 
mechanisms and interactions 
need to be better understood. 
Finally, what is the mean­
ing of the right to health? 
The right to health goes be­
yond access to quality health 
care, although this would be 
a great achievement for 
American society. The pre­
amble to the constitution of 
the World Health Organiza­
tion states that people have a 
right to the highest attainable 
standard of health, and that 
this is fundamental to world 
peace and security. At a 
larger level, the ArDS 
pandemic demonstrates the 
extent of global health-inter­
dependence: An obscure 
event somewhere rapidly 
became a health crisis here 
and around the world. 
Thanks to the generosity 
of the Swiss-based Associa­
tion Francois-Xavier 
Bagnoud, the first academic 
center to focus exclusively 
on health and human rights 
was established in January 
1993 at Harvard. The 
Francois-Xavier Bagnoud 
Center for Health and Hu­
man Rights (named after the 
young Swiss helicopter pilot 
who died on a rescue mis­
sion in West Africa in 1986) 
will link the academic 
strengths of research and 
teaching to field work that 
addresses real public health 
problems. 
For me, the discovery of 
the inextricable relationships 
between health and human 
rights has been a gradual 
process, based on my work 
to fight epidemic disease and 
to promote health. I believe 
that the pragmatic idealism 
of physicians will add tre­
mendous strength to a grow­
ing global capacity to 
prevent disease and promote 
health, as we seek to put 
health and human rights at 
the center of our human 
commitment. • 
Ed Nole: Jonathan Mann, M.D. 
is a 1974 graduate of the School of 
Medicine. He is the former chief of 
the World Health Organization'S 
AIDS programs, director of 
Harvard's Global AIDS Policy 
Coalition and chaired the 8th inter­





SOIl ethillg Ext.-a 
by Steve Kohler 
T he office of Leopo ld Hofstat ter, M.D., is simp le and tidy, al­
most modest. When he's not 
the re, two objects dominate 
the small space: a Webster's 
unabridged dictionary on a 
desk stand and a large paint­
ing on the wall op­
posite . 
The dictionary is 
symboli c of 
Ho fstatter' s close 
acquaintance with 
language and the 
breadth of his inter­
ests. The painting, 
done by his first 
w ife, Lilli , is more 
intimately s ignifi ­
can t. The po rtra it's 
creator as ide, it is 
the subject - a 
young man untm s­
takab ly with a men­
ta I illness, his eyes 
closed and a pain­
full y blank expres­
s ion on his pal e face 
- that embodies 
Hofstatter 's dedica­
ti on to serv ice to 
) 
 others. 
At 91 and s incerely mod­
est, he clea rly is uncom fort­
able being the subject of an 
interview. " [ am just an ordi­
nary huma n being, nothing 
ex tra ," he says, though he 
has in fluenc ed more th an a 
hal f-c entury of psychiatry, 
worked to improve the lot of 
psychiatric patients, pio­
neered more restri cted 
psychosurgica I tecbniq ues 
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Bibl e more appealing and 
accessible to others. 
During the hard days of 
World War I, Hofstatte r pre ­
served food fo r his family 
and app lied a method by 
which their meal s co uld be 
cooked , despite a shortage of 
LeopoLd Hofstatter, M.D. 
spo tlight. "J have a lways 
lived in the serv ice of my 
fell ow man," Hofstatter says. 
The habit began in hi s birth­
place of Vienna , Austria, 
when , as the oldest o f four 
children, he often saw that 
his sisters were ca red fo r. As 
a boy, he collected postca rds 
depicting religious paintings 
- not fo r persona l g rati fica­
tion or gai n but to make tbe 
gas for the stove. Young 
Leopold bu ilt a super-insu ­
.Iated ches t that kep t fo od 
cook ing for fo ur hou rs while 
he was at wal tz and ta ngo 
class with hi s s isters. " We'd 
come home to have rice 
boiled in milk with chocolate 
powder on top ," he says, de­
li ghted at the memory o f 
hav ing done well in adver­
s ity. 
" [ always have a project 
to wo rk on ," Hofstatter says. 
He made a doorbell and the 
crude battery to power it for 
the apartment building his 
fa mily occupied in Vienna. 
The building was construct­
ed before the s iege of Vienna 
by Turk is h troops in 
1683 and had no 
and been named a fe llow in 
the American Associa tion 
for the Advancement of Sci­
ence in honor of his contri­
butions. 
For a lmost a century no w, 
his pre ference has been to 
stay busy, keeping ou t oftbe 
provision fo r electri­
ca l w ires. But 
Hofstatter knew his 
family would app re­
ciate the conve­
nience of a doorbe ll , 
so he created on e. 
His proj ec ts were 
done on the s ide 
while s tudyin g 
Lat in , French and 
Engli sh in schoo l, 
Itali a n, Spanish, 
Russian and 
Croa tian on hi s own . 
A sense of inno­
va ti on inspired by 
common sense a lso 
has in fused 
Hofstatter's profe s­
sionallife and its 
projects. He was 
steered toward medi­
cine by its purpose o f serv­
ing people directl y. A s trong 
sense of anti-militarism born 
of the horror of World W ar 1 
and his un c le ' s du ty as com­
mander of a flame-thrower 
un it bolstered that choice. 
Out of respec t for his pa­
tients as human beings, 
Hofsta tter years la ter was 
responsible for li m iting th e 
extent of su rgery to the fron­
tal lobes when providing re­
lief from otherwise chronic 
and treatment-resistant men­
tal illness. His approach, 
based on the principle, 
"First, do no harm," became 
a milestone in the history of 
psyc hosurgery. 
That may have been his 
greatest single contribution, 
but smaller examples reflect 
the same ethic. When he be­
came assistant superinten­
dent at St. Louis State 
Hospital in the '40s, he 
added a napkin, a glass of 
water, a fork and a knife to 
the place settings at patient's 
meals where previously only 
a spoon had been provided. 
During World War II, he 
made raisins a part of 
most menus, improv­
ing the patients' diets 
with iron. And he in­
sisted on smaller ward 
sizes in the Missouri 
Institute of Psychiatry 
building to encourage 
socializing among pa­
tients and staff. At 
every opportunity, he 
improved psychiatric 
patients' morale by increas­
ing the level of respect 
shown to them. 
When Missouri's gover­
nor came to review changes 
he had made as superinten­
dent at the State School and 
Hospital, Hofstatter turned 
away the politician's con­
gratulations by telling the 
governor, "You don't have 
to be a doctor to understand 
this. Common sense tells 
you. A tool is an extension 
of the arm; all learning is an 
extension of common 
sense." 
During his medical train­
ing at the University of 
Vienna, Hofstatter was asked 
to translate a chemistry pa­
per on newly discovered iso­
topes from English into 
German in preparation for a 
visit from a famous scientist. 
When Albert Einstein ar­
rived in class, Hofstatter 
read the paper to the man he 
came to regard as a hero, and 
the two were photographed 
together with Professor 




Hofstatter intended to be­
come a surgeon, but Nobel 
Prize winner Konstantin von 
Economo saw his transparent 
model of the human brain 
(made from urea, the first 
plastic) and encouraged him 
to direct his attention to neu­
rology and psychiatry - a 
single discipline in Europe at 
the time. 
In early 1938, Hitler's 
armies marched into Vienna. 
The date was March II, 
Hofstatter's birthday. He and 
Lilli soon left and shortly 
therea fter settled in St. 
Louis, where Hofstatter had 
obtained a research fellow­
ship in neurosurgery with 
Ernest Sachs at the medical 
school. He taught applied 
neuroanatomy and, later, 
psychiatry to med ica I stu­
dents. 
During his long involve­
ment in psychiatry, 
Hofstatter has witnessed 
many changes. His early spe­
cia Ity of psychosurgery is 
little practiced since the ad­
vent of psychotropic drugs. 
The paternalistic attitude that 
early psychiatrists some­
times adopted toward their 
patients is gone. Insulin 
therapy, which Hofstatter 
calls "a fraud from the be­
ginning," was for a while 
accepted beyond anyone's 
imagination. And hydro­
therapy "has been given up, 
although it is beneficial," he 
says. 
"Some of the condi tions 
that used to be common are 
almost unknown today," he 
says. "For example, take 
congenital syphilis. Now, we 
treat syphilis early and effec­
tively, so it no longer is 
passed along. I saw many 
tragic instances of general 
paresis of the insane, another 
rare condition today. We 
stopped its progression, but 
we couldn't bring life back 
to the celts killed by invad­
ing spirochetes," is his sad 
observation. 
When he met von 
Economo, the scientist had 
contracted with the Soviet 
government to preserve for 
future study the brains of 
elite thinkers after their 
deaths. The plan was to ex­
amine the brain tissue micro­
scopically to discover the 
source of their genius. 
"Those people were com­
pletely unaware of the 
chemical and electrical pro­
cesses that occur in cerebral 
activity, and there was very 
little to be learned from his­
tological studies," Hofstatter 
says. 
Through it all, Hofstatter 
has kept pace with change. 
Today, he follows the devel­
opment and application of 
brain visualization tech­
niques like positron emission 
tomography (PET) and mag­
netic resonance imaging 
(MRI). He is paliicularly 
interested in applying them 
to the study of the effects of 
early childhood experiences 
on myelination and on social 
behavior. And he partici­
pates in a project for the St. 
Louis Science Center that 
will include history's many 
great thinkers, writers, com­
posers and others who ha ve 
suffered from mental ill­
nesses. 
He spends part of his time 
caring for and playing the 
piano for his wife, Theresa, 
hersel f a pianist. On most 
days, Hofstatter goes to 
his small office to work 
on his projects. He re­
peatedly ponders one 
question: "I've always 
wondered and been sur­
prised at the trust, con­
fidence and respect 
shown me by my fam­
ily, colleagues and su­
periors. I was fortunate 
to have the best teach­
ers and examples to learn 
from and to be inspired by. I 
happened to stumble on a 
few things. I keep myself 
going. [just can't help being 
interested," he says, shifting 
the dictionary to sit squarely 
on his desk. 
Hofstatter characteristi­
cally has avoided honors and 
awards, declining to join 
even most professional soci­
eties. Other rewards have 
been more important. To il­
lustrate, he tells the story of 
how, when Lilli's painting of 
the mental patient had been 
hanging on his wall for some 
time, he encountered the 
man in the portrait. Working 
as an elevator operator, the 
man had been treated suc­
cessfully. "That's what gives 
me satisfaction," he says . • 
A.t every opportllnity~ hp in1IH'O\pd 
psyehiatric patients,) 1110rale by increasing 
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The Coleman Foundation Symposium, presented Friday, 
February 5, treated the subject "Molecular Oncology: Novel 
Approaches to Understanding and Treatment." Among the 
dignitaries on hand were (left to right): Michael W. 
Hennessy, vice-president oIThe Coleman Foundation; John 
E. Hughes, presidellt of The Coleman Foundation; Thomas 
F. Deuel, M.D., symposium organizer and moderator of the 
morning session; Jean D. Thorne, executive director of the 
foundation, and William A. Peck, M.D., executive vice chan­
cellor and dean of the medical school. The Coleman Foun­
dation Symposium, presented annually, rotates among six 
midwestern medical schools andfocuses on recent discover­
ies in basic cancer research. Located in Chicago, the founda­
tion has been a continuous supporter ofthe mel/ical school. 
During his career, Hodges P 'ograul 
organized radiology depart­D dicat d To ments at the University of 
Chicago and the University Paul IIoc ges 
of Florida, trained leaders in 
the field and developed inno­
vative technological ad­he Radiological So­

vancements, such as the 
ciety ofN011h 
phototimer. He taught physi­America (RSNA) 
ology and worked as a dedicated the printed pro­
Roentgenologist in Chinagram of its 78th Scientific 
and returned to the Orient Assembly and Annual Meet­

after his retirement. 
ing to Paul C. Hodges, M.D., 

The RSNA meeting, con­
Ph.D., the oldest living 
vened each year in Chicago, isgraduate of the School of 
the single largest scientific Medicine. Hodges graduated 
meeting held in the country . •in 1918, and he celebrated 
his 100th birthday on Janu­
ary 6, 1993. 
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At its January 25 meeting, the Execu­tive Council of 
WUMCAA voted to name 
Distinguished Alumni Schol­
arships in honor of Leonard 
Berg, M.D. '49; Robert C. 
Drews, M.D. '55; John 
Kissane, M.D. '52, and J. 
Neal Middelkamp, M.D. '48. 
Sixteen such scholarships 
had been established. The 
scholarships are the school's 
major merit-bascd scholar­
ship program funded by pri­
vate support. Funded 
partially by annual gi fts from 
alumni, former residents and 
other donors, they recognize 
beloved teachers. Each 
named scholarship provides 
a first-year recipient with 
$10,000 toward tuition costs. 
The medical school then 
matches the grant up to the 
full amount of tuition. The 
scholarships continue for the 
four years of medical educa­
tion . 
Leonard Berg, M .D. , 
joined the faculty in 1955 as 
an instructor in clinical neu­
rology and was named pro­
fessor in 1972. Today, he is 
director of the Alzheimer's 
Disease Research Center. 
Robert C. Drews, M.D., 
professor of ophthalmology, 
has been on the clinical staff 
since 1966. In 1979, he 
served as the president of 
WUMCAA. 
John Kissane , M.D., 
joined the faculty in 1958 
and is professor of pathology 
in pediatrics. In 1970, he 
was selected Teacher of the 
Year by the graduating class. 
J . Neal Middelkamp, 
M.D., professor of pediat­
rics, has been on the faculty 
since 1953 . He was honored 
with an Alumni/Faculty 
A ward from WUMCAA in 
1988. 
Established in 1989 by 
WUMCAA, the named 
scholarships are not based on 
financial need but on aca­
demic merit and the excep­
tional personal qualities 
required for the successful 





he School of Medi­
cine has received a $1.35 mi Ilion dona­
tion to fund research in the 
division of pulmonary and 
critical care medicine. The 
donation comes from the 
trust of Martin W. Schaefer, 
a Belleville IL native, who 
died in 1991 from emphy­
sema, a common respiratory 
disease that destroys the 
lungs by causing inflamma­
tion of the connective tissue 
framework. Schaefer hoped 
a tmst would fUl1her re­
search and aid in the devel­
opment of new treatments. 
"Emphysema and other 
associated severe respiratory 
disorders constitute a group 
of diseases affecting an in­
creasing segment of our 
adult and aging population," 
says David M. Kipnis, 
M.D., distinguished univer­
sity professor in the Depart­
ment of Internal Medicine. 
"The ability to expand our 
research activities in under­
standing the pathological 
events leading to these disor­
ders and to devise mecha­
nism-based therapeutic 
strategies to treat them repre­
sents an extraordinary oppor­
tunity for our scientists 
engaged in this area of clini­
cal investigation." 
Schaefer was born July 
16, 1923, and attended pub­
lic school in Belleville. He 
was drafted into the U.S. 
Army in 1942 and dis­
charged in 1946, after which 
he joined the Army Reserve . 
He was called back into ser­
vice during the Korean con­
flict and opted for a military 
career at the end of that war. 
He retired as a colonel in 
1970. 
The respiJatory and criti­
cal care division is known 
for its research in asthma 
and pulmonary obstructive 
disease and has the largest 
lung transplant program in 
the world. The division di­
rector is Michael J. 
Holtzman, M.D. • 
AOA Holds 
Banquet 
eonard Slatkin, music 
director and conduc­
tor of the St. Louis 
Symphony Orchestra, was 
the featured speaker at the 
annual initiation banquet of 
the Washington University 
Chapter of Alpha Omega 
Alpha, held at the University 
Club on Wednesday, January 
27. 
Nearly 200 members and 
guests of the chapter at­
tended the induction of 20 
members into the medical 
honor society, the president 
of which is Kenneth M . 
Ludmerer, M.D. 
Fourth-year medical stu­
dents inducted were: Daniel 
E. Buerger, Douglas T. Can­
non, Lynne M. Champagne, 
Paul 1. Cummings, Lora K. 
Eichner, Jodie A. Escobedo, 
Robert A. Fontes, Jr., 
Michele L. Francoeur, 
Patrick R. Gannon, Kirk P. 
Gasper, Cecilia M. 
Redmond, Theodora S. Ross, 
Dan G. Sewell, Vishwas R. 
Talwalkar and Robert J. 
Teaford. Also inducted were 
three graduate trainees: John 
E. Frattini, James R. Howe 
and Charles M. Kilo . 
Each year, the chapter 
elects one new faculty mem­
ber and one new alumnus. 
This year, the new faculty 
member is Patricia L. Cole, 
M.D., assistant professor of 
medicine and associate dean 
for student affairs. The new 
alumnus is Alan J. 
Tiefenbrunn, M.D., associate 
professor of medicine. 
AOA councilor John D. 
Davidson, M.D., coordinated 
the banquet arrangements 
that included entertainment 
by a string quartet composed 
of school of medicine stu­
dents Jacqueline Hoffman 
and Soham Roy from the 
Class of 1995 and Nicole 
Willeumier and Adam Eaton 
from the Class of 1996. 
TI1e AOA chapter will host 
visiting professor Al Tarlov, 
M.D., on April 22 and 23. 
Tarlov, of the division of 
health improvement of the 
Health Institute of the New 
England Medical Center, Bos­
ton, is expected to speak on 






sity has received a $2 million be­
quest from the estate of 
Audrey L. Levin, according 
to an announcement by 
Chancellor William H . 
Danforth, M.D. 
The bequest will establish 
an endowment in the Depart­
ment of Medicine to fund 
one, possibly two, chairs to 
further research into arthritis. 
Mrs . Levin and her husband, 
the late Sam 1. Levin, were 
internationally recognized 
philanthropists and art col­
lectors. They contributed 
many works of art to muse­
ums in Israel and the United 
States, including paintings 
and sculptures to St. Louis 
University, Washington Uni­
versity and the St. Louis Art 
Museum . 
Mrs. Levin was the 
founder of Audrey Levin 
Realtors, a successful real 
estate firm specializing in 
commercial property. She 
was a member of Washing­
ton University's William 
Greenleaf Eliot Society. 
Danforth has called her one 
of hcr generation's great 
benefactors: "She showed us 
how to enjoy life's gifts 
while sharing them with oth­
ers. I am thankful that she 
chose Washington Univer­
sity as a partner in doing 
good for the generations 
ahead." • 
CLAS,~ 
'20s and '30 

Gervais D. Smith, M.D. '22 
Gervais D. Smith, M.D. 
'22, worked as a general 
practitioner in Bolivar MO 
for 66 years. Now 96, he 
lives in a healthcare faci lity 
in Springfield where his wife 
of 52 years spends the day 
with him. She writes that he 
"has always been very proud 
to be a graduate of Washing­
ton University." 
Joseph B. Kendis, M.D. 
'33, writes that he retired 
about five years ago and is 
" living the easy life now," 







11 ~ alcoholism and drug abuse both in private practice and at the Hyland Center at St. 
Anthony's Hospital in St. 
Louis. 
Kenneth M. Amlin, 
M.D. '35, has moved to San 
Mateo CA after living in 
Arnold CA, at an altitude of 
4,000 feet in the Sierra Ne­
vada, for 21 years. He writes 
that he was "tired of being 
snowbound after heavy 
storms." He would like to 
hear from his classmates at 
75 W. 5th Ave., San Mateo 
CA 94402. 
E. Norris Robertson, 
M.D. '37, sends word that he 
and his wife, Mary, have 
been married for 56 years, 
residing in Oklahoma since 
the end of World War II. The 
couple has one son and one 
daughter, two grandsons and 
two granddaughters. 
Robertson is engaged in the 
private practice of ophthal­
mology and holds the rank of 
clinical professor of ophthal­
mology at the University of 
Oklahoma Health Center. 
40 and '.50s 
William S. Curtis, M.D. 
'40, received the University 
of Colorado medal at winter 
commencement exercises at 
the University of Colorado­
Boulder. Curtis is a longtime 
member of the student health 
center medical staff. 
Roland R. Cross, Jr., 
M.D. '40, in November re­
ceived the Stritch Medal 
from Loyola University for 
his contributions that include 
23 years on the admissions 
committee. 
Harry E. Lichtwardt, 
M.D. '43 (December), re­
tired from active practice in 
urology nine years ago when 
he was working as chairman 
of the Department of Urol­
ogy at William Beaumont 
Hospital in Royal Oak MI, 
one of the 10 largest admit­
ting hospitals in the nation. 
He serves on the Executive 
Committee of the American 
Urological Association and 
divides his time between Or­
chard Lake MI, and Naples 
FL. He and his wife, 
Genevieve, also visit their 
three grandchi Idren and two 
sons in California and Mon­
tana. 
James O. Davis, M.D. 
'45, Ph. D., received the Dis­
tinguished Alumni Award 
from the College of Arts and 
Sciences at the University of 
Missouri on February 19. 
Davis, who retired in 1982, 
worked for many years at the 
National Heart Institute and 
did research that led to the 
development of enzyme in­
hibitors used in the treatment 
of heart disease. He served 
as chainnan of the Depart­
ment of Physiology at the 
University of Missouri be­
ginning in 1966, and a pro­
fessorship in cardiovascular 
research is established in his 
name there. 
Robert H. Tanner, M.D. 
'47, has received the special 
service award from Memo­
rial Community Hospital in 
Jefferson City MO. The 
award is presented for out­
standing service to the hospi­
tal, the community and the 
surrounding area. A family 
practitioner, Tanner is a 
member of the medical staff 
at Memorial Community 
Hospital, served on the utili­
zation review committee and 
the board of trustees. He is a 
life member of the hospital's 
board of governors and has 
served as president, vice­
president and secretary/trea­
surer of the medical staffs at 
Memorial and St. Marys 
Health Center. 
Lowell A. Gess, M.D. 
'51, reports that he "emerged 
unscathed from a military 
coup in Sierra Leone, West 
Africa," and planned to do 
more eye surgery at the 
Kissy UMC Eye Hospital in 
Freetown during January, 
February and March of this 
year. 
Marvin E. Levin, M.D. 
'51, and Lawrence \V. 
O'Neal, M.D. '46, have just 
published the fifth edition of 
the text The Diabetic Foot. 
The third editor is John H. 
Bowker, M.D., ofthe Uni­
versity of Miami School of 
Medicine. Recently, Levin 
was a visiting professor in 
Cairo as a guest of the Egyp­
tian Diabetes Care Associa­
tion. 
Philip S. Crossen, M.D. 
'54, has retired from active 
practice but continues as 
medical director at Planned 
Parenthood of Lexington 
KY. He writes, "Doesn't pay 
too well, but it is very satis­
fying, and they don't fire me 
when we are away for ex­
tended time to Michigan in 
summer and Florida in win­
ter." 
'60s lind -70s 
Mary Ann Reynolds, 
M.D. '62, retired from pri­
vate practice on December 
31 , 1992, Harry Reynolds, 
M.D. '60, continues to work 
part-time as a locum tenens 
general surgeon. They write 
that they hope to travel both 
in the U.S. and abroad. The 
couple resides in Turlock 
CA. 
Jim Murdock, M.D. '63, 
and his wife (Marilyn) and 
children live in Eugene OR 
on a small mountain with 
Arabian horses, German 
shepherd dogs and Siamese 
cats . Jim is active in the sur­
gical community at Sacred 
Heart General Hospital and 
keeps up his music, having 
performed with the Eugene 
Symphony. The couple has 
three daughters: Lynn re­
cently graduated from 
Carleton, Elizabeth is a j un­
ior at Yale, and Katie is in 
her first year at Sewanee. 
David L. Dunner, M.D. 
'65, is president of the Soci­
ety of Biological Psychiatry 
for 1992-'93. Dunner is pro­
fessor and vice chairman for 
clinical services in the De­
partment of Psychiatry and 
Behavioral Sciences at the 
University of Washington. 
He edited the recent publ ica­
tion, Current Psychiatric 
Therapy (W.B. Saunders, 
Co., 1993). His wife; Peggy 
Zolbert Dunner, OT '64, 
operates an antique jewelry 
business near Seattle. 
David C. Bisno, M.D. 
'66, sold his Atlanta ophthal­
mology practice in the spring 
30 
I 
of 1992 and has since been 
enjoying studying the history 
of science at Dartmouth Col­
lege and Harvard University. 
He reports that his daughter 
is an "aspiring, although un­
employed," actress, and his 
son is a third-year rabbinical 
student. 
Steven B. Raffin, M.D. 
'68, wrote a chapter for the 
16th edition of the Merck 
Manual. 
Charles L. Rich, M.D. 
'69, has assumed the posi­
tion of chairperson of the 
Department of Psychiatry at 
the Univcrsity of South Ala­
bama. His previous position 
was with the State Univer­
sity of New York at Stony 
Brook. He also is editor-in­
chief of the Annals ofClini­
cal Psychiatf)' and was listed 
recently in the book, The 
Best Doctors in America. 
'80s 
Wilfred G. Ellis, M.D. 
'82, has been awarded the 
AIDS Service A ward from 
the State of Ohio for 1992. 
Ellis has been an advocate 
for his patients and commit­
ted to the local AIDS Task 
Force, as well as being an 
early supporter of the Ryan 
White initiative. He is chair­
man of infectious diseases at 
the St. Rita ' s Medical Center 
in Lima OH. 
FORMEH HOUSE 
T A F F 
Robert Maltz, M.D., 
FRS in otolaryngology, has 
been appointed director of 
the Department of Otolaryn­
gology at Jewish Hospital in 
Cincinnati . He also was 
elected recently to the Coun­
cil of the Cincinnati Acad­
emy of Medicine. 
John S. Spratt, M.D., 
FHS in surgery, is a Naval 
Reserve captain and a clini­
cal professor of surgery at 
the Uniformed Services Uni­
versity for the Health Sci­
ences in Bethesda MD. He 
recently attended the annual 
meeting and luncheon of tile 
editorial advisory board and 
reviewers for the joumal 
Military Medicine. 
Fremont P. Wirth, M.D., 
FRS in neurosurgery, has 
been appointed a director of 
the American Board ofNeu­
rological Surgcons. The 14­
member board, organized in 
1940, is the certifying board 
for neurosurgeons in the 
United States. Wirth prac­
tices in Savannah GA, where 
he currently serves as secre­
tary of the Georgia Medical 
Society. 
o T H E R 
Larry L. Mathis, HA '72 
Larry L. Mathis, RA 
'72, is president and chief 
executive officer of The 
Methodist Hospital System 
and its 10 member corpora­
tions, including The Method­
ist Hospital , a 1,527-bed 
tertiary care, education and 
research facility located in 
the Texas Medical Center in 
Houston. He is chairman­
elect of the board of trustees 
of the American Hospital 
Association. Healtlzweek 
magazine named him one of 
25 top multi, alLiance and 
buying group executives in 
the nation, and Business 
Week named him one of the 
five best managers in non­
profit health services in the 
U.S. 
Calvin R. Robinson, HA '76 
Calvin R. Robinson, HA 
'76, has been appointed to 
the position of vice president 
of operations for Meridia 
Huron Hospital in Cleve­
land. He resides in Cleveland 
Heights. 
Jim Humphrey, RA '87, 
and his wife, Loraine, are 
expecting their first child in 
May. Jim is director of man­
aged care at Corona Medical 
Center in Corona CA. 
Rose J. (Catron) Flynn, 
NU '51, retired at the end of 
January fr0111 the Baptist 
Memorial Hospital System 
in San Antonio TX, after 
working there for 21 years. 
She says her plans are in­
definite, but that she and her 
husband have lots to keep 
them busy, including enjoy­
ing their grandchildren. 
Martha Sue Sublette 
Birk, OT '33 , has lived and 
worked in Decatur lL since 
she married Carl P. Birk, 
M.D. '34, who practiced 
medicine there for 51 years . 
The couple raised three chil­
dren and repOits that many 
members of their extended 
family are Washington Uni­
versity alumni . 
Anne Rothstein Ander­
son, OT '77, her husband, 
Jim, and her son, Paul, live 
in the shadow of Yosemite ' s 
high peaks in Sonora CA. 
Anne owns and operates a 
small therapy practice spe­
cializing in geriatric rehabili­
tation. 
Mrs. George Basinger, 
PT '53, has completed 15 
years as the director of 
physical therapy at the East 
Texas Medical Center ­
Pittsburg. She continues to 
serve the East Texas Re­
gional Healthcare System by 
extending its physical 
therapy service to many 





William J. Harrington, 
M.D., former director of the 
division of hematology here 
and an internationally re­
nowned blood specialist who 
made major discoverics 
about the mechanisms of 
blood disorders from experi­
ments he performed on him­
self, died at his home in 
Miami in October. He was 
68 years old. 
Harrington apparently 
died while repairing a gen­
erator outside his home that 
had been without electricity 
and running water since Hur­
ricane Andrew hit the area 
the week before. 
M.K. King, M.D., 
Danforth Professor of Pre­
ventive Medicine and former 
dean of the medical school , 
says Harrington "was Carl 
Moore's greatest pupil." 
Both men performed experi­
ments on themselves in the 
interest of advancing medi­
cal knowledge. In 1950, 
Harrington discovered that a 
substance in the blood of 
individuals with idiopathic 
thrombocytopenia purpura 
(ITP) destroyed their plate­
lets. He made the discovery 
by injecting a pint of an lTP 
patient's blood into himself. 
Almost immediately, his 
own platelet count dropped . 
He was admitted to Barnes 
Hospital where, within a 
week, his platelet count re­
turned to normal, showing 
that the factor that caused 
ITP was in the blood. 
At age 28, he became the 
youngest member ever 
elected to the American So­
ciety of CI inical Investiga­
tion. Later, he moved to the 
University of Miami, where 
he founded the Center for 
Blood Diseases, became the 
chairman of the Department 
of Medicine and founded the 
Ph.D.IM.D. program. For 25 
years, he worked to improve 
medical education in Latin 
America, and he made house 
calls for as long as he prac­
ticcd. Harrington earned one 
of 70 Mastership awards 
ever granted among the 
60,000 members of the 
American College of Physi­
clans. 
He is survived by his 
wife, Mary, a daughter, three 
sons and four grandchildren. 
Robert A. Huckstep, 
M.D. '48, died on November 
28, 1992, at his home in 
Farmington MO. He was 71 
years old. A community 
leader in Farmington, 
Huckstep had been commit­
ted to education and had 
served on the local board of 
education and the board of 
trustees of Mineral Area 
ColJege for 15 years. He had 
been instrumental in the 
building of Farmington 
Community Hospital. 
Though he had ofticially re­
tired, he continued to work 
part-time at Medical Arts 
Clinic in Farmington. 
Among his survivors are 
his wife, Mary, two sons, 
one daughter, one brother 
and three grandchildren . 
G. Leland Melson, M.D. 
'65, professor of radiology, 
died of cancer on November 
10 at his home in Glendale 
MO. He was 53. 
Melson was a member of 
the medical school faculty 
for 20 years. He was highly 
respected for his work as a 
teacher and clinician, as well 
as for his research on ab­
dominal ultrasound imaging. 
Melson received his 
medical degree from Wash­
ington University in 1965 
and joined the faculty in 
1972 as an instructor at the 
School of Medicine's 
Mallinckrodt Institute of Ra­
diology. He became chief of 
the clinical ultrasound divi­
sion in 1977 and a full pro­
fessor in 1983. 
He received several hon­
ors during his career, includ­
ing being named a member 
of the medical honorary so­
ciety Alpha Omega Alpha 
and a fellow of the American 
College of Radiology. In 
1989, he was recognized by 
the St. Louis Metro Area 
Sonographers for his contri­
butions to the field of ultra­
sound. 
He published more than 
50 scientific journal and 
textbook articles and was an 
active member of several 
professional societies. He 
served on the Missouri Ra­
diological Society board of 
directors, as vice president 
of Alpha Omega Alpha's 
local chapter at Washington 
University and as a past 
president of the Greater St. 
Louis Society of Radiolo­
gists . He also served on a 
consensus-development 
panel for the National Insti­
tutes of Health. 
A memorial service was 
held November 13 at Salem 
United Methodist Church in 
vivors are his wife, Brenda, 
one daughter, two sons, his 
mother, and a sister. 
Jack R. Rhodes, M.D. 
'45, died November 2 of 
natural causes in Sheridan 
WY, while he was attending 
a building dedication at the 
Sheridan Veterans Affairs 
Medical Center. He was 71. 
Rhodes began his general 
surgery practice in Sheridan 
in 1953 and served 30 years 
on the staff of Memorial 
Hospital there, including 
holding the post of chief of 
staff. Rhodes closed his 
practice in 1983, joining the 
staff at Sheridan V A Medi­
cal Center. He retired earlier 
in 1992. 
Rhodes was active in Boy 
Scouts, his church and fra­
temal and professional orga­
nizations. He was an avid 
fisherman and traveler and 
had just retumed from a trip 
to England, Scotland and 
Ireland. H is sudden death 
came as a shock. Survivors 
include his wife, Mary Eliza­
beth, two daughters, five 
sons, a sister and 13 grand­
children . • 
Cal FOI' Nt ~'~M embNS of the 
medical school 
community with 
news for their colleagues are 
invited to send a note to 
Ruth Bebermeyer, Medical 
Alumni and Development 
Office, Box 8049, 660 S. 
Euclid, St. Louis MO 631 10. 
Please include mention of 
the variety and date of your 
affiliation . • 
Ladue. Among Melson's SUf­
32 
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All awards IUllcheoll was held in the King Center on December 8, 1992, to recognize out­
standing achievements by students in the 1991-'92 academic year. Nancy E. MacDonald 
received the CIBA-Geigy Award for Community Service and was presented with the complete 
CIBA Collection of Medical Illustrations prepared by Frank H. Netter, M.D . CIBA ' s Kevin 
Clark made the presentation. Honored along with MacDonald were medical students Michele 
L. Francoeur, Timothy J. McCulley, Lawrence S. KaskO\,vitz, Michael E. Ohl, William L. 
Lyons, Jennifer L. Paterson, Scott M. Pinter, Corina Jo Norrbom, Catherine Bradley, 
Stephanie B. Cox, Ryland E. Melford, Korwyn L. Williams, Marianne Ingels, Martha S. 
Terry, Mathias J. Kill, Lynne M. Champagne, Mark A. Koler and Tamara L. Densmore. 
School of Medicine 
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The birth ofRaja at the St. Louis Zoo on Sunday, December 27, was assisted by 
staff in the endocrine laboratory of the Department of Obstetrits and Gynecol­
ogy. Several elephant births in recent years have been complicated because zoo 
staff could not know exactly when the calf was due. But Janet Willand, Alice 
Hightower and Tonj Broeker of the lab tested the serum progesterone levels of 
Pearl, the mother elephant, regularly. And on Saturday, the 26th, when Pearl's 
progesterone level dropped from the 500-600 picograms per milliliter it had 
averaged to I! 9 picograms, Hightower alerted zoo veterinarians that the birth 
was imminent. Pearl was then monitored closely, and her early signs of labor 
were detected. Raja has captured the city's affection. 
